Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1(-)-trans-delta-9-Tetrahydrocannabinol1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
2(IM) AVONEX®1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
3(R) 3-(5-Dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1- methylethyl) benzamide----1件: 13 💬
40,5 mg Fingolimod1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
50.25 mg RPC1063----3件: 13, 96, 97 💬
60.25mg RPC1063----2件: 13, 97 💬
70.5 mg RPC1063----2件: 13, 97 💬
80.5mg RPC1063----1件: 13 💬
9032166011----1件: 13 💬
10033283045----1件: 13 💬
11034091165----1件: 13 💬
12035418060----1件: 13 💬
131 - Andrographis paniculata p/st extract----1件: 13 💬
141 mg RPC1063----2件: 13, 97 💬
151% Steroid Cream----1件: 13 💬
161-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone----1件: 13 💬
171.0mg RPC1063----1件: 13 💬
1810 milligram (mg) fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
1910000IU vitamin D1件: Vitamin D---1件: 13 💬
2011C-ACETATE2件: Acetate,
Acetic acid C-11		---4件: 6, 13, 86, 88 💬
2111C-BMS-986196----1件: 13 💬
2211C-MCI----1件: 13 💬
2311C-PBR28----2件: 6, 13 💬
2411C-PiB----2件: 6, 13 💬
2511C-PS13----2件: 6, 13 💬
2611C]-PK-11195----1件: 13 💬
2711C]flumazenil1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13 💬
2813-PCV Booster----1件: 13 💬
2913-valent pneumococcal conjugate vaccine (13-PCV)----1件: 13 💬
301393641-34-3----1件: 13 💬
3114C]-RPC1063 Solution (0.1 mg/mL) for Oral Administration----3件: 13, 96, 97 💬
3215 mg fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
3318F-DPA-714 and 18F-FDG1件: Fludeoxyglucose (18F)---1件: 13 💬
3418F-FDG1件: Fludeoxyglucose (18F)---8件: 5, 6, 7, 13, 84, 85, 127, 300 💬
3518F-PM-PBB3----1件: 13 💬
3618F]DPA-714----2件: 13, 127 💬
3719 nor vitamin d1件: Vitamin D---1件: 13 💬
382 - Excipients----1件: 13 💬
392-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate ester1件: Famciclovir1件: Famciclovir 💬--1件: 13 💬
402-CdA1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
412-CdA, 2-chloro-2'-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
422-CdA, 2-chloro-2'-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
432-CdA, 2-chloro-2?-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
442-CdA, 2-chloro-2?-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
452-CdA, 2-chloro-2’-deoxy-beta-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
462-CdA, 2-chloro-2’-deoxy-ß-D-adenosine2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
472-chloro-2'-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
482-chloro-2'-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
492-chloro-2'-deoxyadenosine (2-CdA)1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
502-chloro-2'-deoxyadenosine, 2CdA1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
512-chloro-2?-deoxy-beta-D-adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
522-chloro-2?-deoxy-ß-D-adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
532-chloro-2’-deoxy-beta-D-adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
542-chloro-2’-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
552-chloro-2’-deoxy-ß-D-adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
562-chloro-2’-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine,
Cladribine		2件: Adenosine ,
Cladribine 💬		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬		18件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
572-chloro-2’-deoxyadenosine (2-CdA)1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
5820 mg fampridine-SR (4-aminopyridine, 4-AP)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
5920 mg GA----1件: 13 💬
6020 mg MitoQ----1件: 13 💬
61200106 or EMD 28162----1件: 13 💬
6220mg/0.5ml GA----1件: 13 💬
6320mg/0.5ml glatiramer acetate2件: Acetate,
Glatiramer		---1件: 13 💬
6423-PPV----1件: 13 💬
6523-valent pneumococcal polysaccharide vaccine----3件: 13, 46, 53 💬
6623-valent pneumococcal polysaccharide vaccine (23-PPV)----1件: 13 💬
6725(OH)D3----1件: 13 💬
6825OH-Vitamin D2件: Cholecalciferol,
Vitamin D		1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
692B3-201----1件: 13 💬
703 mg Melatonin1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13 💬
713,4-DIAMINOPYRIDINE----2件: 12, 13 💬
724-Aminopyridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 13 💬
734-AP1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
744.5 mg Naltrexone1件: Naltrexone1件: Naltrexone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
7540 mg GA----2件: 2, 13 💬
7640 mg glatiramer acetate2件: Acetate,
Glatiramer		---2件: 2, 13 💬
7740 mg Glatiramer acetato1件: Glatiramer---1件: 13 💬
7840mg of MitoQ----1件: 13 💬
795 mg Melatonin1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13 💬
805000IU vitamin D1件: Vitamin D---1件: 13 💬
8152069.00.01----1件: 13 💬
829060X----2件: 13, 149 💬
8395% Pure ECGC capsules 200mg----1件: 13 💬
84[123I]CLINDE----2件: 6, 13 💬
85[18F] PBR06----2件: 6, 13 💬
86[18F]-FEPPA----2件: 6, 13 💬
87[18F]Florbetapir PET imaging----1件: 13 💬
88[C-11]Methylreboxetine----1件: 13 💬
89[C-11]PBR28----1件: 13 💬
90[C11]PK-1195 PET scan----1件: 13 💬
91[F-18]PBR06----1件: 13 💬
92[F-18]SDM-8----1件: 13 💬
93[Zr-89]Oxine-labeled leukocytes PET/MRI1件: Oxyquinoline1件: Oxyquinoline 💬--1件: 13 💬
94A4I Antagonist----1件: 13 💬
95AB1010----6件: 2, 5, 6, 13, 46, 96 💬
96Abatacept1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
97Abobotulinumtoxin A----1件: 13 💬
98ABR-215062----1件: 13 💬
99ABR-215062 sodium salt----2件: 13, 96 💬
100ABT-555----1件: 13 💬
101ABT-874/Human monoclonal antibody against IL-12----1件: 13 💬
102ABX-14311件: ABX-1431---1件: 13 💬
103ABX-1431 HCl1件: ABX-1431---1件: 13 💬
104Acetaminophen1件: Acetaminophen1件: Acetaminophen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬13件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337 💬
105Acetaminophen Tablet 650mg1件: Acetaminophen1件: Acetaminophen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
106Acetate1件: Acetate---41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
107Acetazolamide1件: Acetazolamide1件: Acetazolamide 💬13件: CA1,
CA12,
CA13,
CA14,
CA2,
CA3,
CA4,
CA5A,
CA5B,
CA6,
CA7,
CA8,
CA9 💬		7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬6件: 13, 90, 115, 155, 225, 230 💬
108Acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬--21件: 6, 13, 19, 20, 21, 49, 51, 53, 58, 63, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 💬
109ACETYLSALICYLIC ACID1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 51, 210 💬
110Acetylsalicylic acid at 1st visit,1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
111Aciclovir1件: Acyclovir1件: Acyclovir 💬--3件: 13, 28, 60 💬
112Aclasta1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 13, 271, 274 💬
113Aclasta 5 mg Infusionslösung1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
114Aclasta 5mg solution for infusion----1件: 13 💬
115ACT----1件: 13 💬
116ACT-1----1件: 13 💬
117ACT-128800----1件: 13 💬
118ACT-128800 Dose 1----1件: 13 💬
119ACT-128800 Dose 2----1件: 13 💬
120ACT-128800 Dose 3----1件: 13 💬
121ACTH1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 13, 66, 145, 222 💬
122Acthar1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬9件: 2, 13, 14, 46, 49, 50, 66, 84, 222 💬
123Acthar Gel1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬6件: 13, 46, 49, 50, 84, 222 💬
124ACTHAR Gel (ACTH)1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
125Active Comparator receiving Extavia®1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
126Active Control----1件: 13 💬
127ACTOS (Pioglitazone)1件: Pioglitazone1件: Pioglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 13 💬
128Acyclovir1件: Acyclovir1件: Acyclovir 💬--2件: 13, 28 💬
129Ad26.COV2.S----7件: 13, 35, 46, 49, 50, 51, 107 💬
130Adderall XR----1件: 13 💬
131Adderall XR 10 mg----1件: 13 💬
132Adderall XR 5mg----1件: 13 💬
133Adenosine1件: Adenosine1件: Adenosine 💬4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬		12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 13, 58, 65 💬
134Adrenocorticotropic Hormone1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 13, 50, 84 💬
135Adrenocorticotropic hormone (ACTH) gel (H.P. Acthar®)1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
136ADS-5102----2件: 6, 13 💬
137ADS-5102, 137 mg----1件: 13 💬
138ADS-5102, 274 mg----1件: 13 💬
139AERT, (R)-Baclofen1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
140AGEE cream----1件: 13 💬
141AHSC----1件: 13 💬
142AIMSPRO----2件: 13, 51 💬
143AIN----1件: 13 💬
144AIN457----8件: 13, 37, 41, 46, 56, 96, 107, 271 💬
145AL----11件: 5, 6, 7, 13, 28, 51, 67, 86, 97, 114, 127 💬
146Alanine1件: Alanine1件: Alanine 💬--4件: 6, 13, 298, 299 💬
147Albumin (Human) 25%, United States Pharmacopeia (USP)----2件: 13, 14 💬
148Albuterol1件: Salbutamol1件: Albuterol 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 12, 13, 86, 89, 113, 256, 299 💬
149ALEMTUZUMAB1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-17件: 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬
150Alemtuzumab (GZ402673)1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
151Alemtuzumab 12 mg1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
152Alemtuzumab 24 mg1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
153Alemtuzumab GZ4026731件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
154Alemtuzumab immunotherapy1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
155Alemtuzumab Injection1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
156Alemtuzumab Injection [Lemtrada]1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
157Alfuzosin1件: Alfuzosin1件: Alfuzosin 💬1件: ADRA1A 💬7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 13 💬
158ALKS 8700----1件: 13 💬
159ALKS 8700 Delayed Release (DR)1件: Manganese citrate---1件: 13 💬
160ALKS 8700 Delayed Release (DR) Capsule1件: Manganese citrate---1件: 13 💬
161All patients in the study will be treated with ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
162Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells----1件: 13 💬
163Allogeneic umbilical cord mesenchymal stem cells----1件: 13 💬
164AlloRx----8件: 2, 6, 13, 46, 51, 85, 90, 226 💬
165Alpha Lipoic Acid1件: Lipoic acid---1件: 13 💬
166ALPHA-LIPOIC ACID1件: Lipoic acid---2件: 2, 13 💬
167Alpha1-antitrypsin----1件: 13 💬
168ALTRI FARMACI DEL SISTEMA NERVOSO----1件: 13 💬
169ALXN1210----7件: 2, 11, 13, 50, 62, 66, 109 💬
170AMANTADINE1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬4件: 6, 8, 13, 127 💬
171AMANTADINE HYDROCHLORIDE1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 6, 13 💬
172Amantadine Level1件: Amantadine1件: Amantadine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 13 💬
173American Ginseng2件: Ginseng,
Panax quinquefolius whole		1件: Ginseng 💬--1件: 13 💬
174American ginseng extract HT-10012件: Ginseng,
Panax quinquefolius whole		1件: Ginseng 💬--1件: 13 💬
175Amiloride1件: Amiloride1件: Amiloride 💬3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬4件: 13, 67, 225, 299 💬
176Amiloride Hydrochloride1件: Amiloride1件: Amiloride 💬3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 13 💬
177AMILORIDE HYDROCHLORIDE, 2 H2O1件: Amiloride1件: Amiloride 💬3件: SCNN1A,
SCNN1B,
SCNN1G 💬		2件: Aldosterone-regulated sodium reabsorption, Taste transduction 💬1件: 13 💬
178Amilostad----1件: 13 💬
179Amilostad HCT----1件: 13 💬
180Amilostad HCT tablets----1件: 13 💬
181Ampyra1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 6, 13 💬
182Amyvid1件: Florbetapir (18F)---2件: 13, 127 💬
183Amyvid radiopharmaceutical1件: Florbetapir (18F)---1件: 13 💬
184AN100226----2件: 13, 96 💬
185AN100226, BG00002----1件: 13 💬
186Anakinra1件: Anakinra1件: Anakinra 💬2件: IL1R1,
IL1R2 💬		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬16件: 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬
187AndroGel 1 % Topical Gel----1件: 13 💬
188Androgel 10 grams of gel containing 100 mg of testosterone1件: Testosterone1件: Testosterone 💬1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 13 💬
189Andrographolides----1件: 13 💬
190Anesthetic Topical Adhesive Synera----1件: 13 💬
191ANK-700----1件: 13 💬
192Anti LP40 antibody, subclass IgG4 LA294----2件: 13, 46 💬
193Anti-CD25 Humanized Monoclonal Antibody----1件: 13 💬
194Anti-CD52 monoclonal antibody----1件: 13 💬
195Anti-IL-12----2件: 13, 96 💬
196Anti-Mullerian hormone (AMH) level----1件: 13 💬
197Anti-Thymocyte Globulin----18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
198Anticholinergic medication----1件: 13 💬
199Anticuerpo monoclonal anti-LINGO-1 humano----1件: 13 💬
200Antihistamine----2件: 13, 46 💬
201Antimycotic----1件: 13 💬
202Antithymocyte----1件: 13 💬
203ANTITHYMOCYTE IMMUNOGLOBULIN1件: Antithymocyte immunoglobulin (rabbit)---2件: 13, 96 💬
204Antithymocyte immunoglobulin (rabbit)2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---2件: 13, 96 💬
205Anxiety/depression and work and activities----1件: 13 💬
206AP----4件: 2, 6, 13, 299 💬
207Apitox - pure honeybee toxin----1件: 13 💬
208Arbaclofen1件: Arbaclofen1件: Arbaclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬2件: 13, 206 💬
209Arbaclofen ER Tablets1件: Arbaclofen1件: Arbaclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
210Arbaclofen Extended Release Tablets1件: Arbaclofen1件: Arbaclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
211Arbaclofen Placarbil2件: Arbaclofen,
Arbaclofen Placarbil		2件: Arbaclofen placarbil ,
Arbaclofen 💬		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
212Arbaclofen placarbil 15 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: Arbaclofen placarbil ,
Arbaclofen 💬		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
213Arbaclofen placarbil 30 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: Arbaclofen placarbil ,
Arbaclofen 💬		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
214Arbaclofen placarbil 45 mg BID2件: Arbaclofen,
Arbaclofen Placarbil		2件: Arbaclofen placarbil ,
Arbaclofen 💬		2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
215ARICEPT1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬4件: 6, 13, 78, 124 💬
216Aricept 10 mg1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
217Aricept 10 mg filmdragerade tabletter1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
218Aricept 5 mg1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
219Aricept 5 mg filmdragerade tabletter1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
220Arm 1 - GEH120714 (18F) Injection----1件: 13 💬
221Armodafinil1件: Armodafinil1件: Armodafinil 💬1件: SLC6A3 💬7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬3件: 6, 13, 84 💬
222ARN-6039----1件: 13 💬
223Arzerra1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
224ARZERRA - 100 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE(VETRO) - 5 ML(20MG/ML) 3 FLACONI1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
225ARZERRA - 1000 MG - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 50 ML (20 MG/ML) 1 FLACONCINO + 2 KIT DI PROLUNGA1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
226Arzerra®1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
227ASA----3件: 13, 97, 251 💬
228ASB-683699----1件: 13 💬
229Aspirin1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬12件: 13, 22, 46, 49, 51, 58, 64, 86, 113, 158, 210, 231 💬
230Aspirin 650mg Oral Capsule1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
231ATA188----1件: 13 💬
232Atacicept1件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 13, 46, 49, 66 💬
233Atacicept 150 mg1件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 49 💬
234Atacicept 25 mg1件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 66 💬
235Atacicept 75 mg1件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 49, 66 💬
236ATG----4件: 13, 60, 96, 285 💬
237ATL11021件: ATL1102---1件: 13 💬
238Atomoxetine1件: Atomoxetine1件: Atomoxetine 💬1件: SLC6A2 💬1件: Synaptic vesicle cycle 💬4件: 6, 8, 13, 17 💬
239Atorvastatin1件: Atorvastatin1件: Atorvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
240ATX-MS-1467----1件: 13 💬
241AUBAGIO1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
242AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BISTER (ALU/ALU) PERFORATO MONODOSE - 10 X 1 COMPRESSA1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
243AUBAGIO - 14 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (ALU/ALU) - 28 COMPRESSE1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
244Aubagio 14 mg film-coated tablets1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
245Aubagio®1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
246Autologous adipose derived mesenchymal cells----1件: 13 💬
247Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved----1件: 13 💬
248Autologous Bone Marrow-Derived Mononuclear Stem Cells----1件: 13 💬
249Autologous CD4+T cells stimulated and expanded ex vivo by a MOG peptide modified by the introduction of a thioreductase motif into the flanking residues of the T cell epitope----1件: 13 💬
250Autologous Hematopoietic Stem Cell----1件: 13 💬
251Autologous Hematopoietic Stem Cell Transplantation----3件: 13, 49, 84 💬
252Autologous hematopoietic stem cells----1件: 13 💬
253Autologous Mesenchymal Cell Product----1件: 13 💬
254Autologous mesenchymal stem cell transplantation----1件: 13 💬
255Autologous mesenchymal stem cells----5件: 2, 6, 13, 17, 46 💬
256Autologous Stem Cells----2件: 13, 51 💬
257AUTOLOGOUS T-LYMPHOCYTES----1件: 13 💬
258Autologous VitD3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (tolDC-VitD3)1件: Myelin basic protein---1件: 13 💬
259AV605----1件: 13 💬
260AVONEX1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 97 💬
261Avonex (Interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
262Avonex (interferon beta-1a), Biogen Idec Ltd2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
263AVONEX - 30 MCG (6 MILIONI UI) POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 4 FLACONI CON DISPOSITIVO BIOSET + 4 SIRINGHE PRERIEMPITE USO INTRAMUSCOLARE1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
264Avonex 30 microgram/0.5 ml Solution for Injection1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
265AVONEX 30 microgramos/0,5 ml (Interferón Beta - 1a) Solución inyectable1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
266Avonex 30 microgramos/0.5 ml Solución para inyección1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
267AVONEX 30 µg/0,5 ml solution for injection1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
268Avonex and Topamax1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
269AVONEX IM 4SIR 30MCG/0,5ML 4AG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
270AVONEX*IM 4SIR 30MCG/0,5ML+4AG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
271Avonex/Betaseron/Copaxone/Rebif3件: Glatiramer,
Interferon beta-1a,
Interferon beta-1b		2件: Interferon beta-1b ,
Interferon beta-1a 💬		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
272Avonex/Zocor1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
273AVONEX®1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
274Avonex® monotherapy (6.0 MIU administered i.m. each week)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
275AVP-923----3件: 2, 6, 13 💬
276Azathioprine1件: Azathioprine1件: Azathioprine 💬--21件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 💬
277Azathioprine (AZA)1件: Azathioprine1件: Azathioprine 💬--3件: 13, 19, 97 💬
278Azatioprina1件: Azathioprine1件: Azathioprine 💬--3件: 13, 96, 97 💬
279AZATIOPRINA HEX. 50CPR 50MG BL1件: Azathioprine1件: Azathioprine 💬--1件: 13 💬
280Azithromycin1件: Azithromycin2件: Azithromycin ,
Azithromycin 💬		--6件: 13, 84, 85, 96, 228, 299 💬
281B001 injection----1件: 13 💬
282Bacille Calmette-Guerin vaccine----1件: 13 💬
283Bacille of Calmette-Guerin----1件: 13 💬
284Baclofen1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
285Baclofen 20 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
286Baclofen ER Capsules (GRS) 10 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
287Baclofen ER Capsules (GRS) 20 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
288Baclofen ER Capsules (GRS) 30mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
289Baclofen ER Capsules (GRS) 40mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
290Baclofen ER Capsules (GRS) 50 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
291Baclofen IR1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
292Baclofen Tablets USP1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
293Baclofen Tablets USP 10 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
294BAF312----2件: 13, 50 💬
295BAF312 0,25 mg tablet----1件: 13 💬
296BAF312 1 mg tablet----2件: 13, 50 💬
297BAF312 4 mg tablet----1件: 13 💬
298BAF312 hemifumarate----2件: 13, 50 💬
299BAF312A----1件: 13 💬
300Bafiertam1件: Monomethyl fumarate1件: Monomethyl fumarate 💬--1件: 13 💬
301Baminercept1件: Baminercept1件: Baminercept 💬1件: LTB 💬3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 13, 46, 53, 97 💬
302Baseline disease modifying therapies (DMTs)----1件: 13 💬
303Baseline Treatment----1件: 13 💬
304BAT4406F----1件: 13 💬
305BAY 79-4998----1件: 13 💬
306BAY86-5046----1件: 13 💬
307BAY86-5046_Interferon-beta-1b----1件: 13 💬
308Bazedoxifene1件: Bazedoxifene---1件: 13 💬
309Bazedoxifene Acetate2件: Acetate,
Bazedoxifene		---1件: 13 💬
310BBR 2778----2件: 11, 13 💬
311BCD-033 (interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
312BCD-054 180 mcg----1件: 13 💬
313BCD-054 240 mcg----1件: 13 💬
314BCD-063----1件: 13 💬
315BCD-132----1件: 13 💬
316BCD-132, 125 mg----1件: 13 💬
317BCD-132, 500 mg----1件: 13 💬
318BCG20-0134----1件: 13 💬
319BEAM Regimen----1件: 13 💬
320Beetainterferoni -1a----1件: 13 💬
321BELIMUMAB1件: Belimumab1件: Belimumab 💬1件: TNFSF13B 💬4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬13件: 11, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬
322Best Available Therapy (BAT)----1件: 13 💬
323Beta-1b interferoni----1件: 13 💬
324Beta-Alanine2件: Alanine,
beta-Alanine		2件: Alanine ,
beta-Alanine 💬		--1件: 13 💬
325Beta-alanine supplementation2件: Alanine,
beta-Alanine		2件: Alanine ,
beta-Alanine 💬		--1件: 13 💬
326Beta-Carotene1件: Beta carotene1件: beta Carotene 💬--1件: 13 💬
327Beta-Interferon----1件: 13 💬
328BETACAROTENE1件: Beta carotene1件: beta Carotene 💬--1件: 13 💬
329BETAFERON1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
330BETAFERON - 15 FLACONCINI 0.25 MG + 15 FLACONCINI 2 ML1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
331BETAFERON 250 mcg1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
332Betaferon 250 microgram/ml1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
333Betaferon 250 microgram/ml, powder and solvent for solution for injection1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
334Betaferon 250 microgram/mL, powder and solvent for solution for injection.1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
335Betaferon 250 microgramos----1件: 13 💬
336Betaferon 250mcg----1件: 13 💬
337Betaferon 250µg1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
338BETAFERON 500 mcg1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
339Betaferon 500 µg----1件: 13 💬
340Betaferon 500mcg----1件: 13 💬
341Betaferon 500µg1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
342BETAFERON SC 15F 0,25MG 15SIR1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
343BETAFERON*15CONFEZ 0,25MG/ML+1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
344Betaferon/Betaseron----1件: 13 💬
345Betaferon®1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
346BETAFERON® (interferon beta-1b)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
347Betaseron1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
348Betaseron (Interferon beta-1b, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
349Betaseron (Interferon beta-1b, BAY86-5046), Bayer HealthCare AG2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
350Bevacizumab1件: Bevacizumab1件: Bevacizumab 💬1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬6件: 13, 34, 85, 87, 227, 280 💬
351Bexarotene1件: Bexarotene1件: Bexarotene 💬3件: RXRA,
RXRB,
RXRG 💬		17件: Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬2件: 13, 75 💬
352Bexsero4件: Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle,
Neisseria meningitidis serogroup b fhbp fusion protein antigen,
Neisseria meningitidis serogroup b nada protein antigen,
Neisseria meningitidis serogroup b nhba fusion protein antigen		---6件: 11, 13, 61, 62, 66, 222 💬
353BG-12 120----1件: 13 💬
354BG00002----1件: 13 💬
355BG00002 (natalizumab)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
356BG00002-E (natalizumab high titer)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
357BG00012----2件: 13, 46 💬
358BG00012 (DMF)----1件: 13 💬
359BG00012 (DMF) (Tecfidera®.)----1件: 13 💬
360BG0002 (natalizumab)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
361BG9418 (interferon beta 1-a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
362BG9418 (interferon beta-1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 97 💬
363BGC20-0134----1件: 13 💬
364BGG492----1件: 13 💬
365BHT----1件: 13 💬
366BHT-3009----1件: 13 💬
367BHT-3009 0.5 mg----1件: 13 💬
368BHT-3009 1.5 mg----1件: 13 💬
369BHT-3009-01----1件: 13 💬
370BIIB 017----1件: 13 💬
371BIIB017----1件: 13 💬
372BIIB017 (Peginterferon beta-1a)1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
373BIIB019----1件: 13 💬
374BIIB019 (Daclizumab High Yield Process)1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
375BIIB019 (Daclizumab)1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
376BIIB033----1件: 13 💬
377BIIB033 (ANTI-LINGO)----1件: 13 💬
378BIIB033 (ANTI-LINGO) - EV Substance Code SUB118957----1件: 13 💬
379BIIB033 (opicinumab)1件: Opicinumab1件: Opicinumab 💬1件: LINGO1 💬-1件: 13 💬
380BIIB041----1件: 13 💬
381BIIB041 (fampridine)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
382BIIB041 (Fampridine-SR)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
383BIIB041 (PR Fampridine)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
384BIIB061----1件: 13 💬
385BIIB133----1件: 13 💬
386Biobanking with genetic analysis----3件: 13, 51, 56 💬
387Biological samples----1件: 13 💬
388BIOTIN1件: Biotin1件: Biotin 💬--5件: 2, 8, 10, 13, 20 💬
389Biotina1件: Biotin1件: Biotin 💬--2件: 8, 13 💬
390BIRT 2584 XX----1件: 13 💬
391BIRT 2584XX----1件: 13 💬
392Bisacodyl1件: Bisacodyl1件: Bisacodyl 💬--1件: 13 💬
393Blood sample----20件: 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299 💬
394Blood samples----9件: 13, 41, 51, 61, 97, 227, 240, 271, 280 💬
395Blood sampling----5件: 13, 46, 49, 51, 96 💬
396BMMNC----1件: 13 💬
397BMS 188667 (Abatacept)1件: Abatacept1件: Abatacept 💬2件: CD80,
CD86 💬		13件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬1件: 13 💬
398BNT162b2----7件: 13, 35, 46, 49, 50, 51, 107 💬
399BNT162b2, Bivalent----7件: 13, 35, 46, 49, 50, 51, 107 💬
400Bone marrow autologous mesenchymal stem cells transplantation----1件: 13 💬
401BORAGE OIL1件: Borage oil---1件: 13 💬
402BORAGE OIL 20% GLA1件: Borage oil---1件: 13 💬
403BORTEZOMIB2件: Bortezomib,
Bortezomib D-mannitol		1件: Bortezomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬17件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬
404BOSWELAN----1件: 13 💬
405Boswellia Serrata1件: Indian frankincense---1件: 13 💬
406Boswellia Serrata Extract1件: Indian frankincense---1件: 13 💬
407Boswellia serrata extract PS0201Bo capsules1件: Indian frankincense---1件: 13 💬
408Boswellic acids (BOSWELAN)----1件: 13 💬
409Botox1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬7件: 2, 6, 13, 47, 51, 149, 226 💬
410Botox 100 UNT Injection1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
411BOTOX®1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
412Botulinum Toxin----3件: 6, 13, 149 💬
413Botulinum toxin A1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬4件: 13, 51, 149, 226 💬
414BOTULINUM TOXIN A - HAEMAGGLUTININ COMPLEX1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
415BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 💬
416Botulinum Toxin Type A 200U1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
417Botulinum Toxin Type A 300U1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
418Brimonidine1件: Brimonidine1件: Brimonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 13, 90 💬
419Brimonidine tartrate1件: Brimonidine1件: Brimonidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 13, 90 💬
420BX-1----1件: 13 💬
421C1-esterase inhibitor (Cinryze)1件: Human C1-esterase inhibitor---1件: 13 💬
422C105----1件: 13 💬
423Calcio1件: Calcium---4件: 13, 96, 97, 274 💬
424CALCIO FOLINATO DC.IT1件: Calcium---1件: 13 💬
425Calcium2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬		--27件: 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
426Calcium and Vitamin D combination2件: Calcium,
Vitamin D		---1件: 13 💬
427Calcium carbonate3件: Calcium,
Calcium carbonate,
Carbonate ion		2件: Calcium carbonate ,
Calcium carbonate 💬		--8件: 13, 19, 46, 53, 75, 96, 235, 299 💬
428Calcium levofolinate1件: Calcium---1件: 13 💬
429Cannabidiol1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬18件: 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
430Cannabidiol (CBD)1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬7件: 6, 13, 140, 144, 145, 156, 158 💬
431Cannabidiol / Dronabinol capsule 5 mg+2,5 mg2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
432Cannabidiol Botanical Drug Substance (CBD BDS)1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
433Cannabidiol capsule 5 mg1件: Cannabidiol1件: Cannabidiol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
434Cannabis1件: Medical Cannabis---7件: 2, 6, 13, 19, 90, 96, 97 💬
435Cannabis Based Medicine Extract (Sativex)1件: Medical Cannabis---1件: 13 💬
436Cannabis, Medical1件: Medical Cannabis---5件: 2, 6, 13, 96, 97 💬
437Cannador----1件: 13 💬
438Caprylic Triglyceride1件: Tricaprylin---1件: 13 💬
439Capsules with 160 mg Teavigo (at least 94% EGCG)1件: Epigallocatechin gallate---1件: 13 💬
440Carbamazepine1件: Carbamazepine1件: Carbamazepine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 6, 13, 231 💬
441CARBIDOPA1件: Carbidopa1件: Carbidopa 💬1件: DDC 💬9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬7件: 6, 13, 17, 90, 140, 164, 201 💬
442Carbonate1件: Carbonate ion---12件: 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬
443CARBONE VEGETALE----1件: 13 💬
444Carbone vegetale polvere----1件: 13 💬
445Carmustine1件: Carmustine1件: Carmustine 💬--5件: 11, 13, 14, 28, 60 💬
446Carmustine, etoposide, cytarabine, and melphalan (BEAM)4件: Carmustine,
Cytarabine,
Etoposide,
Melphalan		4件: Etoposide ,
Cytarabine ,
Carmustine ,
Melphalan 💬		2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
447Carnitine1件: Levocarnitine1件: Levocarnitine 💬--9件: 5, 13, 58, 86, 96, 97, 265, 298, 316 💬
448Carnosine1件: Carnosine---2件: 6, 13 💬
449Carnosine, capsulle, 2 g/day, 8 weeks1件: Carnosine---1件: 13 💬
450CBD----13件: 2, 6, 8, 13, 36, 46, 51, 140, 144, 145, 156, 158, 206 💬
451CCI-779----2件: 13, 46 💬
452CD----8件: 6, 13, 46, 51, 63, 96, 97, 265 💬
453CDP3231件: CDP323---1件: 13 💬
454CELLCEPT1件: Mycophenolate mofetil1件: Mycophenolate mofetil 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬5件: 11, 13, 42, 43, 49 💬
455Cellular therapy with EBV specific autologous CTL infusion----1件: 13 💬
456Ceralifimod1件: Ceralifimod---1件: 13 💬
457Ceralifmod----1件: 13 💬
458Cerebro-spinal fluid----1件: 13 💬
459Cesamet™ (nabilone)1件: Nabilone1件: Nabilone 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
460Ceterizine----1件: 13 💬
461Cetirizina1件: Cetirizine1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬3件: 13, 28, 300 💬
462Cetirizina Mylan Generics1件: Cetirizine1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
463Cetirizine1件: Cetirizine1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬2件: 13, 35 💬
464CETIRIZINE HYDROCHLORIDE1件: Cetirizine1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
465CGP 77116----1件: 13 💬
466Charcoal----1件: 13 💬
467Chloride1件: Chloride ion---28件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬
468CHOLECALCIFEROL1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
469Cholecalciferol (Vitamin D3)1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬2件: 13, 299 💬
470Cholecalciferol, Vitamin D31件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
471Cholestyramine1件: Cholestyramine---2件: 13, 79 💬
472CHR-1103 / GBR500----1件: 13 💬
473Cianocobalamina1件: Cyanocobalamin4件: Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--1件: 13 💬
474CIANOCOBALAMINA FU DC.IT1件: Cyanocobalamin4件: Cyanocobalamin ,
Cyanocobalamin Co 57 ,
Cyanocobalamin Co 58 ,
Cyanocobalamin Co 60 💬		--1件: 13 💬
475Ciclofosfamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
476Cinryze1件: Human C1-esterase inhibitor---2件: 13, 61 💬
477Circadin1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬3件: 6, 13, 90 💬
478Circadin ( INN= Melatonin)1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬1件: 13 💬
479CISAPRIDE1件: Cisapride2件: Cisapride ,
Cisapride 💬		3件: HTR2A,
HTR3A,
HTR4 💬		7件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
480Citalopram1件: Citalopram1件: Citalopram 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬7件: 6, 8, 13, 18, 46, 98, 127 💬
481CITOCHINE ED IMMUNOMODULATORI----1件: 13 💬
482CLADRIBINA1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
483Cladribina oral1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
484CLADRIBINE1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬3件: 11, 13, 94 💬
485Cladribine (MAVENCLAD®)1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
486Cladribine 3.5 mg/kg1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
487Cladribine 5.25 mg/kg1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
488Cladribine Oral Tablet1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
489Cladribine Pill1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
490Cladribine Tablet1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
491Cladribine Tablets1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
492Clemastine1件: Clemastine1件: Clemastine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
493CLEMASTINE FUMARATE1件: Clemastine1件: Clemastine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
494Clemastine Milstein 1 mg, tabletten1件: Clemastine1件: Clemastine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
495Clostridium botulinum1件: Clostridium botulinum---1件: 13 💬
496CLOSTRIDIUM BOTULINUM TOXIN TYPE A2件: Botulinum toxin type A,
Clostridium botulinum		1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
497CNM-Au8----2件: 2, 13 💬
498Cnp-MS-0601----1件: 13 💬
499CNTO 1275----2件: 13, 96 💬
500CO----3件: 13, 53, 85 💬
501CO-14----1件: 13 💬
502Coconut1件: Coconut---1件: 13 💬
503Coconut oil2件: Coconut,
Coconut oil		1件: Coconut oil 💬--1件: 13 💬
504Coconut oil and epigallocatechin gallate4件: Coconut,
Coconut oil,
Epigallocatechin,
Epigallocatechin gallate		1件: Coconut oil 💬--1件: 13 💬
505COLECALCIFEROL1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬4件: 13, 46, 96, 228 💬
506COLECALCIFEROL CONCENTRATE (OILY FORM)1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
507COLESTIRAMINA1件: Cholestyramine---1件: 13 💬
508Combination Product: ofatumumab with AI1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
509Combination Product: ofatumumab with PRF1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
510Comirnaty1件: Tozinameran1件: Tozinameran 💬--5件: 13, 46, 51, 53, 299 💬
511Comirnaty Konzentrat zur Herstellung einer Injektionsdispersion1件: Tozinameran1件: Tozinameran 💬--1件: 13 💬
512Continue IS (B cell depletion therapy)----7件: 13, 35, 46, 49, 50, 51, 107 💬
513Continue IS (MMF or MPA)----7件: 13, 35, 46, 49, 50, 51, 107 💬
514Continue IS (MTX)----7件: 13, 35, 46, 49, 50, 51, 107 💬
515Continued Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
516Control group----4件: 2, 13, 46, 70 💬
517COP----1件: 13 💬
518COP-11件: Glatiramer---1件: 13 💬
519COP-1/Copolymer-11件: Glatiramer---1件: 13 💬
520COPAXONE1件: Glatiramer---1件: 13 💬
521COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE 28 SIRINGHE PRERIEMPITE1件: Glatiramer---1件: 13 💬
522COPAXONE - 20 MG/ML SOLUZIONE INIETTABILE IN SIRINGHE PRERIEMPITE 30 SIRINGHE1件: Glatiramer---1件: 13 💬
523COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN1件: Glatiramer---1件: 13 💬
524COPAXONE - 40 MG/ML SOLUZIONE INIETTABILE IN SIRINGA PRERIEMPITA 12 SIRINGHE PRERIEMPITE DA 1 ML CON AGO1件: Glatiramer---1件: 13 💬
525Copaxone 20 mg1件: Glatiramer---1件: 13 💬
526Copaxone 20 mg/ml1件: Glatiramer---1件: 13 💬
527COPAXONE 20 mg/ml solución inyectable en jeringa precargada1件: Glatiramer---1件: 13 💬
528Copaxone 20 mg/ml solución para inyección en jeringa precargada1件: Glatiramer---1件: 13 💬
529Copaxone 20 mg/ml Solution for Injection, pre-filled syringe1件: Glatiramer---1件: 13 💬
530Copaxone 20 mg/ml, Solution for Injection, pre-filled syringes1件: Glatiramer---1件: 13 💬
531Copaxone 20mg/ml Solution for Injection, pre-filled syringe1件: Glatiramer---1件: 13 💬
532Copaxone 40 mg/ml1件: Glatiramer---1件: 13 💬
533Copaxone 40 mg/ml solution for injection, pre-filled syringe1件: Glatiramer---1件: 13 💬
534Copaxone subcutaneous injection syringe1件: Glatiramer---1件: 13 💬
535COPAXONE*SC 28SIR 20MG/ML1件: Glatiramer---1件: 13 💬
536Copaxone-Teva1件: Glatiramer---1件: 13 💬
537Copaxone®1件: Glatiramer---1件: 13 💬
538Copolymer 1----1件: 13 💬
539Copolymer-11件: Glatiramer---1件: 13 💬
540Corticosteroid----9件: 13, 42, 43, 44, 45, 66, 96, 97, 222 💬
541Corticosteroids & tanCART19/20----1件: 13 💬
542Corticotropin1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬7件: 2, 13, 46, 75, 81, 84, 222 💬
543COVID-19 mRNA Vaccine (nucleoside modified)----3件: 13, 46, 51 💬
544COVID-19 mRNA vaccine (nucleoside-modified)----4件: 13, 46, 51, 299 💬
545COVID-19 mRNA vaccine Moderna (CX-024414)----4件: 13, 46, 51, 299 💬
546COVID-19 vaccination----1件: 13 💬
547COVID19 vaccine----1件: 13 💬
548Cranberry1件: Cranberry---1件: 13 💬
549CRM1971件: Corynebacterium diphtheriae CRM197 protein---3件: 11, 13, 46 💬
550CS-0777 tablets----1件: 13 💬
551CSF sampling----1件: 13 💬
552CT103A cells----2件: 11, 13 💬
553Curcumin1件: Curcumin---10件: 2, 13, 46, 67, 74, 94, 96, 97, 139, 299 💬
554Cyclophosfamide----1件: 13 💬
555Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬
556Cyclophosphamide (drug)1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
557Cyclophosphamide and ATG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
558Cyclophosphamide and fludarabine2件: Cyclophosphamide,
Fludarabine		3件: Cyclophosphamide ,
Cyclophosphamide ,
Fludarabine 💬		1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬2件: 11, 13 💬
559CYCLOPHOSPHAMIDE MONOHYDRATE1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--4件: 13, 60, 96, 256 💬
560Cyclophosphamide/ATG1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
561Cyclophosphamide/Glatiramer acetate3件: Acetate,
Cyclophosphamide,
Glatiramer		2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
562Cyclophosphamide/Rituximab2件: Cyclophosphamide,
Rituximab		3件: Cyclophosphamide ,
Rituximab ,
Cyclophosphamide 💬		1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
563CYMBALTA1件: Duloxetine1件: Duloxetine 💬2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬3件: 6, 13, 49 💬
564Cysteine1件: Cysteine---10件: 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬
565Cytarabine1件: Cytarabine1件: Cytarabine 💬--7件: 11, 13, 14, 25, 49, 60, 65 💬
566Cytolytic CD4+ T cells----1件: 13 💬
567Cápsulas de Laquinimod 0.6 mg1件: Laquinimod---1件: 13 💬
568Células madre mesenquimales----1件: 13 💬
569D Mannose1件: Mannose---1件: 13 💬
570D-aspartate----1件: 13 💬
571D-BIOTIN1件: Biotin1件: Biotin 💬--3件: 10, 13, 20 💬
572D-BIOTINA1件: Biotin1件: Biotin 💬--1件: 13 💬
573DAC----1件: 13 💬
574DAC HYP----1件: 13 💬
575DAC-HYP----1件: 13 💬
576DACLIZUMAB1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬8件: 13, 56, 60, 65, 97, 107, 283, 284 💬
577Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
578Daclizumab High Yield Process1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
579DACLIZUMAB HYP1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
580Daclizumab HYP (DAC HYP1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
581Daclizumab HYP (DAC HYP)1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
582Daclizumab wih Greek suffix1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
583Daclizumab with Greek suufix1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
584Dalfampridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 4, 13 💬
585Dalfampridine ER1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
586Dalfampridine ER, 10 Mg Oral Tablet, Extended Release1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
587Dalfampridine-ER 10mg1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
588Dalfampridine-ER 5mg1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
589Dantrolene1件: Dantrolene1件: Dantrolene 💬--2件: 13, 233 💬
590DAPIROLIZUMAB PEGOL1件: Dapirolizumab pegol---2件: 13, 49 💬
591Daratumumab1件: Daratumumab1件: Daratumumab 💬1件: CD38 💬7件: Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬5件: 13, 28, 48, 49, 63 💬
592Darifenacin1件: Darifenacin1件: Darifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬2件: 6, 13 💬
593Darifenacin (BAY79-4998)1件: Darifenacin1件: Darifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 13 💬
594DC-TAB----1件: 13 💬
595Dekristol----2件: 13, 97 💬
596Dekristol 20000 IE----1件: 13 💬
597Dekristol® 400-Tabletten----1件: 13 💬
598Dekristol®-Tablette 1 (400 IE)----1件: 13 💬
599Delta-9-tetrahydrocannabinol1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬3件: 8, 13, 36 💬
600DEMESTRIL SEPTEM----1件: 13 💬
601Desloratadine1件: Desloratadine1件: Desloratadine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
602Desloratadine given orally1件: Desloratadine1件: Desloratadine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
603Dexamethason----4件: 13, 28, 46, 331 💬
604Dexamethasone1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
605Dexamethasone given orally1件: Dexamethasone1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
606Dexamethasone soduim phosphate2件: Dexamethasone,
Phosphate ion		1件: Dexamethasone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
607Dexchlorpheniramine1件: Dexchlorpheniramine1件: Dexchlorpheniramine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬2件: 13, 49 💬
608Dexrazoxane1件: Dexrazoxane1件: Dexrazoxane 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
609Dexrazoxane (DRZ) plus Mitoxantrone (MX)2件: Dexrazoxane,
Mitoxantrone		2件: Dexrazoxane ,
Mitoxantrone 💬		2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
610Dextromethorphan1件: Dextromethorphan1件: Dextromethorphan 💬6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬
611DEXTROMETHORPHAN HYDROBROMIDE1件: Dextromethorphan1件: Dextromethorphan 💬6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬2件: 13, 46 💬
612Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: Dextromethorphan ,
Quinidine 💬		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13 💬
613Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg3件: Dextromethorphan,
Quinidine,
Sulfate ion		2件: Dextromethorphan ,
Quinidine 💬		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬2件: 2, 13 💬
614Dextromethorphan/Quinidine2件: Dextromethorphan,
Quinidine		2件: Dextromethorphan ,
Quinidine 💬		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
615Dextrometorfano1件: Dextromethorphan1件: Dextromethorphan 💬6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 13 💬
616DEXTROMETORFANO HIDROBROMURO1件: Dextromethorphan1件: Dextromethorphan 💬6件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SIGMAR1 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬1件: 13 💬
617Dextrometorfano/Quinidina2件: Dextromethorphan,
Quinidine		2件: Dextromethorphan ,
Quinidine 💬		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
618Diazoxide1件: Diazoxide1件: Diazoxide 💬2件: ABCC8,
KCNJ11 💬		4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬2件: 13, 193 💬
619DIBASE----1件: 13 💬
620Diclofenac1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬5件: 13, 34, 46, 78, 271 💬
621Diclofenac sodium topical gel1件: Diclofenac1件: Diclofenac 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
622DIMETHYL FUMARATE1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬4件: 13, 51, 86, 296 💬
623Dimethyl Fumarate (DMF)1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬3件: 13, 51, 86 💬
624Dimethyl fumarate 240 mg1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
625Dimethyl fumarate [DMF]1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
626DIMETIL-FUMARATO----1件: 13 💬
627Dimetilfumarato----1件: 13 💬
628Diphenhydramine1件: Diphenhydramine1件: Diphenhydramine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬8件: 11, 13, 49, 51, 70, 86, 222, 256 💬
629Diphenhydramine IV1件: Diphenhydramine1件: Diphenhydramine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
630Diphenydramine----1件: 13 💬
631Diphtheria toxoid1件: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)---2件: 13, 46 💬
632Diroximel Fumarate1件: Diroximel fumarate1件: Diroximel fumarate 💬--1件: 13 💬
633Diroximel Fumarate (DRF)1件: Diroximel fumarate1件: Diroximel fumarate 💬--1件: 13 💬
634Dirucotide1件: Dirucotide1件: Dirucotide 💬--1件: 13 💬
635Dirucotide acetate2件: Acetate,
Dirucotide		1件: Dirucotide 💬--1件: 13 💬
636Discontinuation of disease modifying therapy----1件: 13 💬
637Disease Modifying therapy----1件: 13 💬
638Disease modifying treatment (DMT)----1件: 13 💬
639Divozilimab----1件: 13 💬
640DMT----1件: 13 💬
641DMT continuation----1件: 13 💬
642Domperidone1件: Domperidone2件: Domperidone ,
Domperidone maleate 💬		1件: DRD2 💬8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬5件: 6, 13, 17, 51, 230 💬
643Donepezil1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬9件: 5, 6, 13, 46, 78, 124, 127, 156, 206 💬
644Donepezil HCI (drug)1件: Donepezil1件: Donepezil 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 13 💬
645Dosing Interruption of Natalizumab1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
646Dotarem1件: Gadoteric acid1件: Gadoteric acid 💬--1件: 13 💬
647Dotarem 0,5mmol/ml,1件: Gadoteric acid1件: Gadoteric acid 💬--1件: 13 💬
648Doxycycline1件: Doxycycline2件: Doxycycline ,
Doxycycline 💬		--17件: 13, 23, 28, 34, 46, 84, 85, 89, 96, 97, 158, 161, 162, 167, 227, 280, 299 💬
649DPA----5件: 2, 6, 13, 85, 127 💬
650DPA-714 PET/MRI----1件: 13 💬
651Dronabinol1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬5件: 2, 13, 46, 271, 298 💬
652Dronabinol 25 mg/ml, oral drops1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
653Dronabinol capsule 2,5 mg1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
654Drug - SHR1459----1件: 13 💬
655Duloxetine1件: Duloxetine1件: Duloxetine 💬2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 6, 13 💬
656Duloxetine Hydrochloride (HCI)1件: Duloxetine1件: Duloxetine 💬2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13 💬
657DUOC-01----3件: 13, 19, 20 💬
658DYDROGESTERONE1件: Dydrogesterone1件: Dydrogesterone 💬1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
659Dysport1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬2件: 13, 36 💬
660DYSPORT*SC IM 2FL 500U1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
661DYSPORT®1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
662Early Harvest Extra Virgin Olive Oil2件: Olea europaea leaf,
Olive oil		1件: Olive oil 💬--1件: 13 💬
663EBIXA1件: Memantine1件: Memantine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬3件: 2, 6, 13 💬
664ECP002A----1件: 13 💬
665ECULIZUMAB1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 11, 13, 14, 61, 62, 109, 222 💬
666EFALIZUMAB1件: Efalizumab1件: Efalizumab 💬1件: ITGAL 💬12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬8件: 11, 13, 37, 46, 53, 61, 95, 96 💬
667EGb 761® (Tanakan®)1件: Ginkgo biloba---1件: 13 💬
668EGCG1件: Epigallocatechin gallate---9件: 6, 8, 13, 17, 28, 85, 113, 206, 299 💬
669EHP-101 25 mg BID----1件: 13 💬
670EHP-101 25 mg OD----1件: 13 💬
671EHP-101 50 mg BID----1件: 13 💬
672EHP-101 50 mg OD----1件: 13 💬
673EK-12----1件: 13 💬
674Elezanumab1件: Elezanumab1件: Elezanumab 💬1件: RGMA 💬2件: Axon guidance, TGF-beta signaling pathway 💬1件: 13 💬
675ELND002----1件: 13 💬
676EMD 28162----1件: 13 💬
677Emselex1件: Darifenacin1件: Darifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 13 💬
678EMSELEX 15 mg Retardtabletten1件: Darifenacin1件: Darifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 13 💬
679EMSELEX 7,5 mg Retardtabletten1件: Darifenacin1件: Darifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 13 💬
680ENA713----2件: 6, 13 💬
681Encapsulated Baclofen 20 mg1件: Baclofen1件: Baclofen 💬2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬1件: 13 💬
682Encapsulated Simvastatin tablets1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
683ENDOXAN----7件: 13, 28, 43, 44, 85, 96, 222 💬
684Endoxan - ciclofosfamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
685ENDOXAN BAXTER----3件: 13, 43, 96 💬
686Enspryng1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
687EPARMEFOLIN 30 CPR 0,1/0,5MG----1件: 13 💬
688Epigallocatechin1件: Epigallocatechin---5件: 8, 13, 28, 85, 113 💬
689Epigallocatechin gallate2件: Epigallocatechin,
Epigallocatechin gallate		---1件: 13 💬
690Epigallocatechin-gallate (Sunphenon)1件: Epigallocatechin---1件: 13 💬
691EPO----1件: 13 💬
692Epoetin alfa1件: Erythropoietin---3件: 13, 18, 46 💬
693Epoetin beta1件: Erythropoietin---1件: 13 💬
694Equal----4件: 6, 13, 67, 86 💬
695Erypo/Erypo FS----1件: 13 💬
696ERYTHROPOIETIN1件: Erythropoietin---9件: 2, 6, 13, 18, 22, 47, 70, 95, 96 💬
697Escitalopram1件: Escitalopram1件: Escitalopram 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 2, 6, 13, 46 💬
698Escitalopram oxalate antidepressant1件: Escitalopram1件: Escitalopram 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13 💬
699Esomeprazole1件: Esomeprazole1件: Esomeprazole 💬2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬8件: 13, 46, 86, 98, 107, 113, 298, 299 💬
700Essential fatty acids----1件: 13 💬
701Estradiol1件: Estradiol1件: Estradiol 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬7件: 13, 46, 49, 65, 76, 226, 299 💬
702ESTRADIOL HEMIHYDRATE1件: Estradiol1件: Estradiol 💬2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 13 💬
703Estriol1件: Estriol2件: Estriol ,
Estriol tripropionate 💬		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬2件: 13, 227 💬
704Estroprogestins----1件: 13 💬
705Eszopiclone1件: Eszopiclone1件: Eszopiclone 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬3件: 6, 13, 46 💬
706ETHINYLESTRADIOL1件: Ethinylestradiol1件: Ethinyl estradiol 💬1件: ESR1 💬9件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 13 💬
707ETIMS----1件: 13 💬
708ETIMS (EDC-fixed autologous PBMCs coupled with 7 immunodominant myelin peptides in MS patients)1件: Myelin basic protein---1件: 13 💬
709Etoposide1件: Etoposide1件: Etoposide 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
710EU/1/08/454/001-002, EU/1/08/454/005-007----1件: 13 💬
711EU/1/95/003/005-010----1件: 13 💬
712EU/1/97/033/002----1件: 13 💬
713EU/1/98/063/001-003----1件: 13 💬
714EU/1/98/063/004-006----1件: 13 💬
715EVOBRUTINIB1件: Evobrutinib1件: Evobrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬3件: 13, 46, 49 💬
716Evobrutinib 10mg1件: Evobrutinib1件: Evobrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13 💬
717Evobrutinib 25mg1件: Evobrutinib1件: Evobrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13 💬
718EXELON1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬2件: 6, 13 💬
719Exelon transdermales Pflaster----1件: 13 💬
720Experimental Glatiramer Acetate2件: Acetate,
Glatiramer		---1件: 13 💬
721Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS----1件: 13 💬
722EXTAVIA1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
723Extavia (interferon beta-1b), Novartis Pharma AG2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
724Extavia 250 microgram/ml1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
725Extavia 250 micrograms/ml1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
726EXTAVIA*SC 15FL 250MCG/ML+15SI1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
727Extavia®1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
728Extended release fampridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
729Extended-release oxycodone1件: Oxycodone1件: Oxycodone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
730Extended-release quetiapine fumarate1件: Quetiapine1件: Quetiapine 💬2件: DRD2,
HTR2A 💬		11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬1件: 13 💬
731F-18 3F4AP----1件: 13 💬
732F-18 FEDAA1106 (BAY85-8101)----1件: 13 💬
733Famciclovir1件: Famciclovir1件: Famciclovir 💬--2件: 11, 13 💬
734FAMPRIDINA1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
735FAMPRIDINE1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14 💬
736Fampridine SR1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
737Fampridine-SR1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
738Fampridine-SR b.i.d. (Twice Daily)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
739FAMPYRA1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 13, 14 💬
740FAMPYRA - 10 MG - COMPRESSA A RILASCIO PROLUNGATO - USO ORALE - FLACONE (HDPE) 56 COMPRESSE (4 FLACONI DA 14)1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
741Fampyra 10 mg prolonged-release tablets2件: Dalfampridine,
Manganese citrate		1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
742Fampyra 10mg prolonged release tablets2件: Dalfampridine,
Manganese citrate		1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
743Fatigue----1件: 13 💬
744Febuxostat1件: Febuxostat1件: Febuxostat 💬1件: XDH 💬6件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Peroxisome, Purine metabolism 💬3件: 2, 6, 13 💬
745Fecal microbial transplant (FMT)----1件: 13 💬
746Fecal Microbial Transplants----1件: 13 💬
747Fecal microbiota----3件: 13, 96, 97 💬
748Femoston 1/10----1件: 13 💬
749Femoston 2/10----1件: 13 💬
750FENEBRUTINIB1件: Fenebrutinib1件: Fenebrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 13 💬
751Feraheme1件: Ferumoxytol1件: Ferumoxytol 💬--1件: 13 💬
752Ferumoxytol1件: Ferumoxytol1件: Ferumoxytol 💬--1件: 13 💬
753Fexofenadine1件: Fexofenadine1件: Fexofenadine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬2件: 13, 46 💬
754Filgrastim1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬28件: 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
755Fingolimob----1件: 13 💬
756Fingolimob (FTY)----1件: 13 💬
757FINGOLIMOD1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 14, 156 💬
758Fingolimod (FTY720)1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 156 💬
759Fingolimod 0.5 mg1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
760Fingolimod 0.5mg1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
761Fingolimod 1.25 mg1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
762FINGOLIMOD HYDROCHLORIDE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
763Fingolimodi----1件: 13 💬
764Fingolmod----1件: 13 💬
765Firategrast1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
766Firategrast (USAN approved name)1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
767Firategrast 150 mg1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
768Firategrast 300 mg1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
769Firategrast gastro-retentive solution1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
770Firategrast immediate release tablet1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
771Firategrast modified release tablet1件: Firategrast1件: Firategrast 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
772First line DMT----1件: 13 💬
773Fish Oil1件: Fish oil---8件: 13, 46, 49, 66, 96, 260, 294, 299 💬
774Fish oil concentrate1件: Fish oil---1件: 13 💬
775FISH OIL, RICH IN OMEGA-3-ACIDS2件: Fish oil,
Omega-3 fatty acids		---1件: 13 💬
776FISH OIL,RICH IN OMEGA 3 ACIDS1件: Fish oil---1件: 13 💬
777FLUDARA1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
778Fludarabine1件: Fludarabine1件: Fludarabine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬19件: 11, 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 286, 326 💬
779Flumazenil1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬5件: 6, 13, 17, 18, 206 💬
780Fluoxetin1件: Fluoxetine1件: Fluoxetine 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬3件: 13, 179, 206 💬
781Fluoxetin Hexal1件: Fluoxetine1件: Fluoxetine 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13 💬
782FLUOXETINE1件: Fluoxetine1件: Fluoxetine 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 13, 17, 78, 86 💬
783FLUOXETINE HYDROCHLORIDE1件: Fluoxetine1件: Fluoxetine 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬1件: 13 💬
784Flupirtin----1件: 13 💬
785Flupirtine1件: Flupirtine1件: Flupirtine 💬--1件: 13 💬
786Flupirtinmaleat----1件: 13 💬
787FLURBIPROFEN1件: Flurbiprofen1件: Flurbiprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬3件: 13, 21, 46 💬
788FMP30 Donor Stool----1件: 13 💬
789FolateScan (Technetium Tc 99mEC20)----4件: 13, 46, 49, 96 💬
790Foralumab1件: Foralumab---2件: 13, 96 💬
791Formistin----1件: 13 💬
792FORMISTIN - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE----1件: 13 💬
793Formistin 10 mg----1件: 13 💬
794Formulation A----1件: 13 💬
795Formulation B----1件: 13 💬
796Formulation C----1件: 13 💬
797Formulation D----1件: 13 💬
798FTY720----2件: 13, 14 💬
799FTY720D----1件: 13 💬
800Fully humanized anti-human IL-6 receptor (IL-6R) neutralizing monoclonal antibody----1件: 13 💬
801Fumaric acid1件: Fumaric acid1件: Fumaric acid 💬--1件: 13 💬
802Fusion2件: Iron polymaltose,
Lactobacillus casei		1件: Lactobacillus casei 💬--7件: 11, 13, 46, 49, 69, 70, 271 💬
803G-CSF1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬16件: 2, 6, 11, 13, 16, 22, 47, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬
804G2-SFM (IFN-beta-1a from clone 484-39,FBS-free process)----1件: 13 💬
805GA----1件: 13 💬
806GA 20 mg/mL----1件: 13 💬
807GA 40 mg/mL----1件: 13 💬
808GA Depot----1件: 13 💬
809GA Depot 25mg once monthly----1件: 13 💬
810GA Depot 40 mg----1件: 13 💬
811GA Depot 40mg once monthly----1件: 13 💬
812GA Depot 80 mg----1件: 13 💬
813GABAPENTIN1件: Gabapentin1件: Gabapentin 💬5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬5件: 6, 13, 19, 70, 298 💬
814Gabapentine1件: Gabapentin1件: Gabapentin 💬5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
815Gabapentine 300mg1件: Gabapentin1件: Gabapentin 💬5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
816Gadobenate1件: Gadobenic acid1件: Gadobenic acid 💬--1件: 13 💬
817Gadobenate Dimeglumine1件: Gadobenic acid1件: Gadobenic acid 💬--1件: 13 💬
818GADOBUTROL1件: Gadobutrol1件: Gadobutrol 💬--2件: 13, 22 💬
819Gadolinium1件: Gadolinium---4件: 13, 34, 46, 65 💬
820Gadolinium-based contrast1件: Gadolinium---1件: 13 💬
821Gadoteric acid1件: Gadoteric acid1件: Gadoteric acid 💬--1件: 13 💬
822Gadoteridol1件: Gadoteridol1件: Gadoteridol 💬--1件: 13 💬
823Gadovist----2件: 13, 22 💬
824GADOVIST 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado----1件: 13 💬
825Gadovist 1.0 mmol/ml Injektionslösung1件: Gadobutrol1件: Gadobutrol 💬--1件: 13 💬
826Gamma-Tocopherol2件: Tocopherol,
gamma-Tocopherol		1件: Tocopherol 💬--1件: 13 💬
827GBP----1件: 13 💬
828GDC-0853----3件: 13, 46, 49 💬
829GDC-0853 RO7010939----3件: 13, 46, 49 💬
830Genotropin1件: Somatotropin---5件: 13, 78, 107, 187, 193 💬
831Gilenya1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 2, 13, 14 💬
832GILENYA - 0.25 MG - CAPSULE RIGIDE - USO ORALE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
833GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
834GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER DIVISIBILE PER DOSE UNITARIA(PVC/PVDC/ALU) SCATOLA DA 7X1 CAPSULE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
835GILENYA - 0.5 MG - CAPSULE RIGIDE - USO ORALE - BLISTER(PVC/PVDC/ALU) SCATOLA DA 28 CAPSULE1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
836Gilenya / Imusera1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
837Gilenya 0,5 mg Hartkapseln1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
838Gilenya®1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
839Gileyna----1件: 13 💬
840Ginkgo1件: Ginkgo biloba---5件: 6, 13, 18, 47, 90 💬
841Ginkgo biloba1件: Ginkgo biloba---4件: 13, 18, 47, 90 💬
842Ginseng1件: Ginseng1件: Ginseng 💬--3件: 13, 46, 53 💬
843GLA----2件: 13, 19 💬
844Glatiramer1件: Glatiramer---4件: 2, 13, 96, 156 💬
845GLATIRAMER ACETATE2件: Acetate,
Glatiramer		---3件: 13, 96, 156 💬
846Glatiramer Acetate (Copaxone®)2件: Acetate,
Glatiramer		---2件: 13, 156 💬
847Glatiramer Acetate (DB)2件: Acetate,
Glatiramer		---1件: 13 💬
848Glatiramer Acetate (GA)2件: Acetate,
Glatiramer		---1件: 13 💬
849Glatiramer Acetate (GA) 40 mg2件: Acetate,
Glatiramer		---1件: 13 💬
850Glatiramer Acetate (GTR)2件: Acetate,
Glatiramer		---1件: 13 💬
851Glatiramer Acetate (OL)2件: Acetate,
Glatiramer		---1件: 13 💬
852Glatiramer acetate 150mg enteric coated tablets2件: Acetate,
Glatiramer		---1件: 13 💬
853Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets2件: Acetate,
Glatiramer		---1件: 13 💬
854Glatiramer acetate 20 mg2件: Acetate,
Glatiramer		---1件: 13 💬
855Glatiramer acetate 20 mg, with mitoxantrone3件: Acetate,
Glatiramer,
Mitoxantrone		1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
856Glatiramer Acetate 20 mg/0.5 mL2件: Acetate,
Glatiramer		---1件: 13 💬
857Glatiramer acetate 40 mg2件: Acetate,
Glatiramer		---1件: 13 💬
858Glatiramer Acetate [GA]2件: Acetate,
Glatiramer		---1件: 13 💬
859Glatiramer acetate injection with oral cetirizine hydrochloride3件: Acetate,
Cetirizine,
Glatiramer		1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
860Glatiramer acetate with minocycline3件: Acetate,
Glatiramer,
Minocycline		1件: Minocycline 💬--1件: 13 💬
861Glatiramer acetate, (Copaxone®)2件: Acetate,
Glatiramer		---1件: 13 💬
862Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b2件: Acetate,
Glatiramer		---1件: 13 💬
863Glatiramer Acetate, N-Acetylcysteine3件: Acetate,
Acetylcysteine,
Glatiramer		1件: Acetylcysteine 💬--1件: 13 💬
864GLATIRAMER ACETATO1件: Glatiramer---1件: 13 💬
865GLATIRAMERO ACETATO----1件: 13 💬
866Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato----1件: 13 💬
867Glucose2件: D-glucose,
Dextrose, unspecified form		1件: Glucose 💬--12件: 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299 💬
868Glutamate and aspartate----1件: 13 💬
869Glycerol1件: Glycerin1件: Glycerin 💬--5件: 6, 13, 79, 316, 317 💬
870Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate1件: Glycerin1件: Glycerin 💬--1件: 13 💬
871GNbAC1----1件: 13 💬
872GNbAC1 Monoclonal Antibody----1件: 13 💬
873Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 💬
874Gold Nanocrystals1件: Gold---3件: 2, 6, 13 💬
875Granulocyte-colony stimulating factor (G-CSF) and prednisone2件: Filgrastim,
Prednisone		2件: Prednisone ,
Filgrastim 💬		2件: CSF3R,
NR3C1 💬		6件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 13 💬
876Growth hormone1件: Somatotropin---14件: 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299 💬
877GSK1223249----2件: 2, 13 💬
878GSK1841157----3件: 13, 35, 46 💬
879GSK2018682----1件: 13 💬
880GSK2018682 CD2 Capsule----1件: 13 💬
881GSK2018682 CD3 micronised Tablet----1件: 13 💬
882GSK2018682 CD3 non-micronised Tablet----1件: 13 💬
883GSK2018682 CD3 non-micronised Tablet in fed state----1件: 13 💬
884GSK239512----1件: 13 💬
885GSK2395612----1件: 13 💬
886GSK3888130B----1件: 13 💬
887GTR----1件: 13 💬
888GTR.ace----1件: 13 💬
889GUANABENZ1件: Guanabenz1件: Guanabenz 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬2件: 2, 13 💬
890GW-1000-02----1件: 13 💬
891GYLENIA----1件: 13 💬
892GYLENIA 0,5 mg----1件: 13 💬
893GZ402668----1件: 13 💬
894GZ402673----1件: 13 💬
895H.P. Acthar Gel (repository corticotropin injection)1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
896H5G1.1-mAb----3件: 13, 50, 62 💬
897HAEMOPHILUS TYPE B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---2件: 13, 14 💬
898HB-adMSCs1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins---5件: 2, 6, 13, 14, 46 💬
899HBM9161 Injection----1件: 13 💬
900Helminth ova----1件: 13 💬
901Hematopoietic Stem Cell Transplantation----12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬
902Heterologous booster----1件: 13 💬
903Hiberix1件: Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen---4件: 13, 61, 62, 66 💬
904Hidrocloruro de fingolimod1件: Fingolimod1件: Fingolimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 14 💬
905High Dose Aspirin (1300 mg/day)1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
906High Dose MYOBLOC1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
907High Phenolic Extra Virgin Olive Oil2件: Olea europaea leaf,
Olive oil		1件: Olive oil 💬--1件: 13 💬
908High/Low Sodium Diet----1件: 13 💬
909Histidine1件: Histidine1件: Histidine 💬--3件: 13, 169, 170 💬
910HMR 1726D----1件: 13 💬
911HMR1726----1件: 13 💬
912HMR1726D----1件: 13 💬
913Homologous booster----1件: 13 💬
914Hookworm larvae----1件: 13 💬
915HP184----1件: 13 💬
916Human anti-IL-12 IgG1 Mab----1件: 13 💬
917Human anti-IL-12 Mab----1件: 13 💬
918Human anti-LINGO-1 monoclonal antibody----1件: 13 💬
919Human autologous mesenchymal stem cells----2件: 2, 13 💬
920Human fetal-derived Neural Stem Cells (hNSCs)----1件: 13 💬
921Human interferon beta1件: Human interferon beta---2件: 13, 26 💬
922Human interferon beta 1a (Rebif)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
923Human interferon beta-1a and glatiramer acetate4件: Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
924HUMAN LEUCOCYTE INTERFERON-ALPHA----1件: 13 💬
925Human monoclonal antibody (CNTO 1275) to interleukin-12p40----1件: 13 💬
926Human Neural Stem Cells----2件: 2, 13 💬
927Human normal immunoglobulin1件: Human immunoglobulin G---9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
928Human recombinant growth hormone1件: Somatotropin---2件: 13, 299 💬
929Human Umbilical Cord Mesenchymal Stem Cells1件: Human Umbilical Cord Mesenchymal Stem Cells---3件: 13, 96, 113 💬
930HuMax-CD201件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 13, 46 💬
931HYDROCHLOROTHIAZIDE1件: Hydrochlorothiazide1件: Hydrochlorothiazide 💬1件: SLC12A3 💬-4件: 13, 67, 225, 235 💬
932Hydroxychloroquine1件: Hydroxychloroquine1件: Hydroxychloroquine 💬--27件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
933Hydroxychloroquine Pill1件: Hydroxychloroquine1件: Hydroxychloroquine 💬--1件: 13 💬
934Hydroxychloroquine sulfate2件: Hydroxychloroquine,
Sulfate ion		1件: Hydroxychloroquine 💬--4件: 13, 46, 53, 66 💬
935Hydroxyurea1件: Hydroxyurea1件: Hydroxyurea 💬1件: RRM2 💬7件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬8件: 3, 13, 19, 20, 65, 85, 86, 284 💬
936Hyperimmune caprine serum against HIV lysate----1件: 13 💬
937IBUDILAST1件: Ibudilast1件: Ibudilast 💬8件: CYSLTR1,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PTGIR 💬		16件: Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 2, 13 💬
938Ibuprofen1件: Ibuprofen1件: Ibuprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬7件: 13, 46, 65, 107, 113, 271, 299 💬
939Ibuprofen Sandoz 400 mg Filmtabletten1件: Ibuprofen1件: Ibuprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
940Idebenone1件: Idebenone1件: Idebenone 💬--6件: 6, 8, 13, 18, 113, 302 💬
941IFA Incomplete Freund's Adjuvant----1件: 13 💬
942IFN beta 1a 44 mcg TIW----1件: 13 💬
943IFN beta-1a----1件: 13 💬
944IFN ß-1a----1件: 13 💬
945IFN-beta-1a (Rebif®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
946IFN-beta-1a, (Avonex®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
947IFN-ß-1a (Rebif®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
948IFN-ß-1a, (Avonex®)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
949IL2----3件: 13, 60, 95 💬
950IM90838----3件: 13, 96, 97 💬
951Imatinib1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
952IMATINIB MESILATE1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬3件: 13, 86, 88 💬
953Imatinib Mesylate1件: Imatinib1件: Imatinib 💬3件: ABL1,
KIT,
PDGFRA 💬		32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬5件: 13, 28, 34, 51, 86 💬
954IMCY-01411件: IMCY-0141---1件: 13 💬
955Immune globulin----3件: 11, 13, 14 💬
956Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified----1件: 13 💬
957Immunoglobulin----3件: 13, 14, 63 💬
958IMMUNOGLOBULIN G----8件: 2, 11, 13, 14, 49, 50, 63, 65 💬
959IMMUNOSUPPRESSIVE AGENTS----2件: 13, 50 💬
960IMS001----1件: 13 💬
961IMU-838----3件: 13, 96, 97 💬
962IMU-838 (30 mg/day)----1件: 13 💬
963IMU-838 (45 mg/day)----1件: 13 💬
964IMU-838 tablets----1件: 13 💬
965IMU-838-RC----1件: 13 💬
966IMUREL----4件: 13, 46, 96, 97 💬
967IncabotulinumtoxinA----1件: 13 💬
968Incobotulinum Toxin A----3件: 2, 6, 13 💬
969Indapamide1件: Indapamide1件: Indapamide 💬1件: SLC12A3 💬-1件: 13 💬
970Indapamide Pill1件: Indapamide1件: Indapamide 💬1件: SLC12A3 💬-1件: 13 💬
971INEBILIZUMAB1件: Inebilizumab1件: Inebilizumab 💬1件: CD19 💬5件: B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬4件: 11, 13, 51, 300 💬
972INF beta-1a----1件: 13 💬
973Influenza vaccine----5件: 11, 13, 46, 51, 84 💬
974Inhaled Cannabis1件: Medical Cannabis---1件: 13 💬
975Injectable MS DMT----1件: 13 💬
976Injection of autologous bone marrow derived mesenchymal stem cells----1件: 13 💬
977Injection of cell free media----1件: 13 💬
978INN COLECALCIFEROL1件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
979Inosine1件: Inosine1件: Inosine 💬--5件: 2, 6, 13, 17, 122 💬
980Insulin----6件: 6, 13, 46, 75, 78, 299 💬
981INT131----1件: 13 💬
982Inteferone Beta-1A----1件: 13 💬
983Interferon Beta1件: Human interferon beta---6件: 13, 20, 26, 50, 96, 97 💬
984INTERFERON BETA - 1A1件: Human interferon beta---1件: 13 💬
985Interferon beta - 1a (IFN)1件: Human interferon beta---1件: 13 💬
986Interferon beta -1b1件: Human interferon beta---1件: 13 💬
987Interferon Beta 11件: Human interferon beta---1件: 13 💬
988Interferon Beta 1-A2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
989Interferon beta 1-b (Betaferon/Betaseron, BAY86-5046)1件: Human interferon beta---1件: 13 💬
990Interferon Beta 1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
991Interferon beta 1a 30 ug IM once weekly2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
992Interferon Beta 1a pegilado2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
993Interferon beta 1a, oral doxycycline3件: Doxycycline,
Human interferon beta,
Interferon beta-1a		3件: Doxycycline ,
Interferon beta-1a ,
Doxycycline 💬		2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
994Interferon beta 1B1件: Human interferon beta---1件: 13 💬
995Interferon beta 1b (Betaseron, BAY86-5046)1件: Human interferon beta---1件: 13 💬
996Interferon Beta Therapy1件: Human interferon beta---1件: 13 💬
997Interferon beta treatment to add-on atorvastatin treatment2件: Atorvastatin,
Human interferon beta		1件: Atorvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
998Interferon beta-1 a1件: Human interferon beta---1件: 13 💬
999INTERFERON BETA-1A2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬4件: 13, 26, 96, 97 💬
1000Interferon beta-1a (Avonex)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1001INTERFERON BETA-1A (Avonex®)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1002Interferon beta-1a (current approved manufacturing process invloving FBS)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1003Interferon beta-1a (new process, manufactured without FBS)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1004Interferon beta-1a (Rebif)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1005Interferon beta-1a (Rebif®) alone2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1006Interferon beta-1a 30 µg2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1007Interferon beta-1a FBS-free/HSA free, RNF2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1008Interferon beta-1a FBS-free/HSA-free2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1009Interferon beta-1a FBS-free/HSA-free, RNF2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1010Interferon beta-1a HSA+ biosimilar2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1011Interferon beta-1a HSA-free biosimilar2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1012Interferon beta-1a original2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1013Interferon Beta-1A Prefilled Syringe2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1014Interferon beta-1a, 30 µg/0.5 ml2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1015INTERFERON BETA-1B2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1016Interferon beta-1b (Betaferon, BAY 86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1017Interferon beta-1b (Betaferon, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1018Interferon beta-1b (Betaferon/Betaseron, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1019Interferon beta-1b (Betaferon®, BAY 86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1020Interferon beta-1b (Betaseron, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1021Interferon beta-1b (Betaseron, Betaferon, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1022Interferon beta-1b (PF530, Betaferon)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1023Interferon beta-1b and Tacrolimus3件: Human interferon beta,
Interferon beta-1b,
Tacrolimus		3件: Tacrolimus ,
Interferon beta-1b ,
Tacrolimus 💬		7件: IFNAR1,
IFNAR2,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		48件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Epstein-Barr virus infection, Glucagon signaling pathway, Glutamatergic synapse, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
1024Interferon beta-1b group2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1025Interferon beta-1b, (Betaseron BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1026Interferon beta-1b, FRP about 6 weeks after randomization2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1027Interferon beta-1b, FRP within 15 days after randomization2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1028Interferon beta-1b/Atorvastatin group3件: Atorvastatin,
Human interferon beta,
Interferon beta-1b		2件: Interferon beta-1b ,
Atorvastatin 💬		3件: HMGCR,
IFNAR1,
IFNAR2 💬		22件: AMPK signaling pathway, Bile secretion, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Terpenoid backbone biosynthesis, Toll-like receptor signaling pathway 💬1件: 13 💬
1029INTERFERON BETA1A----1件: 13 💬
1030Interferon ß-1a----1件: 13 💬
1031Interferon ß-1a 30 µg----1件: 13 💬
1032Interferon ß-1b----1件: 13 💬
1033Interferon-1beta (Betaseron, BAY86-5046)1件: Interferon beta-1b1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1034Interferon-Beta1件: Human interferon beta---2件: 13, 97 💬
1035Interferon-beta (IFN-beta)1件: Human interferon beta---1件: 13 💬
1036Interferon-beta 1a1件: Human interferon beta---1件: 13 💬
1037Interferon-beta 1a FBS-free/HSA free, RNF1件: Human interferon beta---1件: 13 💬
1038Interferon-beta 1a FBS-free/HSA-free, RNF1件: Human interferon beta---1件: 13 💬
1039Interferon-beta 1b1件: Human interferon beta---1件: 13 💬
1040Interferon-beta 1b (Betaseron)1件: Human interferon beta---1件: 13 💬
1041Interferon-beta [IFN-beta]1件: Human interferon beta---1件: 13 💬
1042Interferon-beta and human leukocyte Interferon-a1件: Human interferon beta---1件: 13 💬
1043Interferon-beta-11件: Human interferon beta---1件: 13 💬
1044Interferon-beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬2件: 13, 97 💬
1045Interferon-beta-1a (Avonex) plus methylprednisolone3件: Human interferon beta,
Interferon beta-1a,
Methylprednisolone		2件: Methylprednisolone ,
Interferon beta-1a 💬		3件: IFNAR1,
IFNAR2,
NR3C1 💬		19件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1046Interferon-beta-1a FBS-free/HSA free, RNF2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1047Interferon-beta-1a FBS-free/HSA-free2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1048Interferon-beta-1b2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1049Interferon-beta-1b (BETASERON, BAY 86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1050Interferon-beta1----1件: 13 💬
1051Interferon-ß----1件: 13 💬
1052Interferon-ß [IFN-ß]----1件: 13 💬
1053Interferon-ß-1----1件: 13 💬
1054Interferon-ß-1a----1件: 13 💬
1055Interferon-ß-1b----1件: 13 💬
1056Interferone----1件: 13 💬
1057Interferone beta 1a----1件: 13 💬
1058INTERFERONE BETA 1B----1件: 13 💬
1059Interferone beta-1a----1件: 13 💬
1060Interferone Beta-1B----1件: 13 💬
1061Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab12件: Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		10件: Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod 💬		7件: CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬		30件: Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬1件: 13 💬
1062Interferón beta 1a----1件: 13 💬
1063Interferón beta 1a pegilado----1件: 13 💬
1064Interferón Beta-1a pegilado----1件: 13 💬
1065Intradetrusor injection of Botulinum Toxin-A----1件: 13 💬
1066Intranasal Foralumab Solution1件: Foralumab---1件: 13 💬
1067Intratect----4件: 13, 14, 35, 65 💬
1068Intrathecal administration of autologous MSC-NP----1件: 13 💬
1069Intrathecal methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 13 💬
1070Intrathecal MSC-NP injection----1件: 13 💬
1071Intravenous (IV) infusions----2件: 13, 97 💬
1072Intravenous Immunoglobulin----7件: 13, 14, 35, 38, 39, 51, 309 💬
1073Intravenous injection of mesenchymal stem cells----1件: 13 💬
1074Intravenous Methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 13, 145 💬
1075Intravenous steroid----1件: 13 💬
1076IPX056----1件: 13 💬
1077IPX056 10 mg----1件: 13 💬
1078IPX056 20 mg----1件: 13 💬
1079IPX056 30 mg----1件: 13 💬
1080IPX056 35 mg----1件: 13 💬
1081IPX056 40 mg----1件: 13 💬
1082IPX056-10 mg----1件: 13 💬
1083IPX056-20 mg----1件: 13 💬
1084IPX056-25 mg----1件: 13 💬
1085IPX056-30 mg----1件: 13 💬
1086IPX056-35 mg----1件: 13 💬
1087IPX056-40 mg----1件: 13 💬
1088IR902----1件: 13 💬
1089Iron oxide1件: Ferric oxide1件: Ferric oxide 💬--1件: 13 💬
1090ISENTRESS1件: Raltegravir1件: Raltegravir 💬--1件: 13 💬
1091Isoxsuprine1件: Isoxsuprine1件: Isoxsuprine 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
1092Isoxsuprine Hydrochloride1件: Isoxsuprine1件: Isoxsuprine 💬1件: ADRB2 💬9件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
1093IV methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1094IV methylprednisolone (steroids)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1095IVIG1件: Human immunoglobulin G---7件: 11, 13, 14, 17, 50, 51, 65 💬
1096Ixazomib1件: Ixazomib1件: Ixazomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬4件: 13, 16, 28, 51 💬
1097Ixazomib (NINLARO®) capsules1件: Ixazomib1件: Ixazomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 13 💬
1098JM----2件: 6, 13 💬
1099JM-4----1件: 13 💬
1100JNJ-67896153/ACT-128800----1件: 13 💬
1101Kemstro----1件: 13 💬
1102Kepivance1件: Palifermin1件: Palifermin 💬1件: FGFR2 💬13件: Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬1件: 13 💬
1103KEPPRA1件: Levetiracetam1件: Levetiracetam 💬1件: SV2A 💬1件: ECM-receptor interaction 💬1件: 13 💬
1104Keppra 250mg1件: Levetiracetam1件: Levetiracetam 💬1件: SV2A 💬1件: ECM-receptor interaction 💬1件: 13 💬
1105Keppra 500mg1件: Levetiracetam1件: Levetiracetam 💬1件: SV2A 💬1件: ECM-receptor interaction 💬1件: 13 💬
1106Keppra ®1件: Levetiracetam1件: Levetiracetam 💬1件: SV2A 💬1件: ECM-receptor interaction 💬1件: 13 💬
1107Kesimpta1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1108Kesimpta 20 mg Injektionslösung im Fertigpen1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1109Kesimpta 20 mg solution for injection in pre-filled pen1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1110KETAMINE1件: Ketamine1件: Ketamine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬6件: 6, 13, 70, 113, 156, 215 💬
1111Ketoconazole1件: Ketoconazole1件: Ketoconazole 💬1件: CYP17A1 💬6件: Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬3件: 8, 13, 75 💬
1112Keyhole limpet hemocyanin1件: Keyhole limpet hemocyanin---2件: 13, 46 💬
1113Keyhole limpet hemocyanin (KLH)1件: Keyhole limpet hemocyanin---1件: 13 💬
1114Keyhole limpet hemocyanin (KLH) neo-antigen1件: Keyhole limpet hemocyanin---1件: 13 💬
1115KLH----2件: 13, 65 💬
1116L-000124467----2件: 13, 46 💬
1117L-Carnitine1件: Levocarnitine1件: Levocarnitine 💬--7件: 13, 86, 96, 97, 265, 298, 316 💬
1118L-Histidine1件: Histidine1件: Histidine 💬--1件: 13 💬
1119L01BB04----1件: 13 💬
1120L03 AB----1件: 13 💬
1121L03 AB 08----1件: 13 💬
1122L03 AB07----1件: 13 💬
1123L03AB13----1件: 13 💬
1124L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE1件: Antithymocyte immunoglobulin (rabbit)---1件: 13 💬
1125L04AA31----1件: 13 💬
1126LA----5件: 6, 13, 76, 78, 256 💬
1127Lactose1件: Lactose2件: Anhydrous lactose ,
Lactose 💬		--6件: 2, 6, 13, 97, 228, 310 💬
1128Lactose monohydrate1件: Lactose2件: Anhydrous lactose ,
Lactose 💬		--1件: 13 💬
1129Lactulose1件: Lactulose1件: Lactulose 💬--3件: 13, 96, 291 💬
1130Lamotrigine1件: Lamotrigine1件: Lamotrigine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬5件: 13, 34, 38, 114, 144 💬
1131Lamotrigine extended release tablets1件: Lamotrigine1件: Lamotrigine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
1132LAQUINIMOD1件: Laquinimod---4件: 8, 13, 49, 96 💬
1133Laquinimod 0.31件: Laquinimod---1件: 13 💬
1134Laquinimod 0.61件: Laquinimod---1件: 13 💬
1135Laquinimod 1.21件: Laquinimod---1件: 13 💬
1136Laquinimod Capsulas 0.6 mg1件: Laquinimod---1件: 13 💬
1137Laquinimod Capsules 0.3 mg1件: Laquinimod---1件: 13 💬
1138Laquinimod Capsules 0.6 mg1件: Laquinimod---1件: 13 💬
1139Laquinimod Sodium (USAN)1件: Laquinimod---1件: 13 💬
1140Laquinimod Tablets 0.3 mg1件: Laquinimod---1件: 13 💬
1141Lemtrada1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-2件: 13, 65 💬
1142LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
1143Lenograstim1件: Lenograstim1件: Lenograstim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬7件: 2, 13, 16, 18, 19, 57, 65 💬
1144Levetiracetam1件: Levetiracetam1件: Levetiracetam 💬1件: SV2A 💬1件: ECM-receptor interaction 💬5件: 2, 4, 6, 13, 307 💬
1145Levitra1件: Vardenafil1件: Vardenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬2件: 13, 86 💬
1146Levocarnil----1件: 13 💬
1147Levofolene1件: Levoleucovorin---1件: 13 💬
1148LEVOFOLENE 4 MG 30 CPR1件: Levoleucovorin---1件: 13 💬
1149LEVONORGESTREL1件: Levonorgestrel1件: Levonorgestrel 💬1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
1150LFB-R603----1件: 13 💬
1151LFB-R603, TGTX1101----1件: 13 💬
1152Lidocaine1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬12件: 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 256 💬
1153Lidocaine patch 5%1件: Lidocaine2件: Lidocaine ,
Lidocaine hydrochloride monohydrate 💬		5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
1154Linoleic acid1件: Linoleic acid---4件: 2, 5, 13, 299 💬
1155Linoleic Acid/Oleic Acid2件: Linoleic acid,
Oleic Acid		1件: Oleic acid 💬--1件: 13 💬
1156Liofen XL----1件: 13 💬
1157Liothyronine1件: Liothyronine1件: Liothyronine 💬2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬3件: 13, 210, 212 💬
1158Liothyronine sodium1件: Liothyronine1件: Liothyronine 💬2件: THRA,
THRB 💬		2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬1件: 13 💬
1159Lipoic acid1件: Lipoic acid---5件: 2, 5, 13, 14, 20 💬
1160Lipoic acid (LA) with fish oil and LA without fish oil2件: Fish oil,
Lipoic acid		---1件: 13 💬
1161Lipoic acid and omega-3 fatty acids2件: Lipoic acid,
Omega-3 fatty acids		---1件: 13 💬
1162Lisdexamfetamine1件: Lisdexamfetamine1件: Lisdexamfetamine 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
1163Lisdexamfetamine sulfate2件: Lisdexamfetamine,
Sulfate ion		1件: Lisdexamfetamine 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
1164Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field----1件: 13 💬
1165LITHIUM CARBONATE3件: Carbonate ion,
Lithium carbonate,
Lithium citrate		2件: Lithium carbonate ,
Lithium citrate 💬		--5件: 2, 13, 17, 18, 127 💬
1166Live Hookworm Larvae----1件: 13 💬
1167Live Necator americanus larvae----1件: 13 💬
1168Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI)----1件: 13 💬
1169Lodosyn----1件: 13 💬
1170Loperamide1件: Loperamide1件: Loperamide 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬2件: 13, 97 💬
1171Loratadine1件: Loratadine1件: Loratadine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬4件: 13, 46, 89, 98 💬
1172LOU064----2件: 13, 53 💬
1173LOU064C1----1件: 13 💬
1174Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day1件: Vitamin D---1件: 13 💬
1175Low Dose Aspirin (162 mg/day)1件: Acetylsalicylic acid1件: Aspirin 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
1176Low dose cannabis1件: Medical Cannabis---1件: 13 💬
1177Low Dose MYOBLOC1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
1178Low immunogenic interferon-beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1179LP-168 tablet----1件: 13 💬
1180Lu AG06466----1件: 13 💬
1181LUBIPROSTONE1件: Lubiprostone1件: Lubiprostone 💬1件: CLCN2 💬1件: Mineral absorption 💬4件: 6, 13, 290, 299 💬
1182Lumbar puncture----4件: 13, 96, 97, 127 💬
1183Lutein1件: Lutein---3件: 13, 90, 164 💬
1184LUTENYL----1件: 13 💬
1185LY2127399----3件: 13, 46, 49 💬
1186LY248686----1件: 13 💬
1187Lysine1件: Lysine1件: Lysine 💬--4件: 13, 97, 228, 299 💬
1188M2951----3件: 13, 46, 49 💬
1189MABCAMPATH1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-2件: 13, 60 💬
1190MABCAMPATH 10 mg/ml concentrado para solución para perfusión1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
1191MabCampath ®1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
1192MabCampath-1h1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
1193MabCampath®1件: Alemtuzumab1件: Alemtuzumab 💬1件: CD52 💬-1件: 13 💬
1194MabThera1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬22件: 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬
1195MabThera (Rituximab)1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬4件: 13, 46, 49, 53 💬
1196Mabthera or biosimilar rituximab product1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1197Mabthera®1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬6件: 13, 35, 43, 44, 46, 93 💬
1198Maltodextrin1件: Maltodextrin1件: Maltodextrin 💬--4件: 6, 13, 96, 97 💬
1199Mangafodipir1件: Mangafodipir1件: Mangafodipir 💬--1件: 13 💬
1200Mangafodipir (Teslascan)1件: Mangafodipir1件: Mangafodipir 💬--1件: 13 💬
1201Mannitol1件: Mannitol1件: Mannitol 💬--7件: 6, 13, 28, 60, 96, 113, 299 💬
1202Mannose1件: Mannose---2件: 13, 256 💬
1203MANTADAN*20CPR 100MG----1件: 13 💬
1204Marijuana1件: Medical Cannabis---1件: 13 💬
1205Masitinb mesylate----1件: 13 💬
1206MASITINIB1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬6件: 2, 5, 6, 13, 46, 96 💬
1207Masitinib (4.5)1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 2, 13 💬
1208Masitinib mesilate1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬2件: 2, 13 💬
1209MASITINIB MESYLATE1件: Masitinib1件: Masitinib 💬1件: KIT 💬11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬6件: 2, 5, 6, 13, 46, 96 💬
1210Mastinib----1件: 13 💬
1211MAVENCLAD1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
1212MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
1213MAVENCLAD 10 mg tablets1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
1214Mavenclad tabletter 10 mg1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
1215Mavenclad®1件: Cladribine1件: Cladribine 💬1件: RRM1 💬6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Nucleotide metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
1216Mayzent1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1217Mayzent 0,25 mg Filmtabletten1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1218Mayzent 0.25 mg fi1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1219Mayzent 2 mg film-coated tablets1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1220Mayzent 2 mg Filmtabletten1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1221MBP----1件: 13 💬
1222MBP peptide----1件: 13 💬
1223MBP8298----1件: 13 💬
1224MBP8298 Synthetic Peptide----1件: 13 💬
1225MD1003----5件: 2, 10, 13, 14, 20 💬
1226MD1003 100mg capsule----1件: 13 💬
1227MEDI-551----2件: 13, 51 💬
1228MEDI-551 100 MG-IV----1件: 13 💬
1229MEDI-551 30 MG-IV----1件: 13 💬
1230MEDI-551 300 MG-SC----1件: 13 💬
1231MEDI-551 60 MG-SC----1件: 13 💬
1232MEDI-551 600 MG-IV----1件: 13 💬
1233Medical Marijuana1件: Medical Cannabis---1件: 13 💬
1234Medrol1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬4件: 13, 46, 56, 222 💬
1235Megadose oral methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1236Melatonin1件: Melatonin1件: Melatonin 💬2件: MTNR1A,
MTNR1B 💬		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬12件: 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬
1237Melphalan1件: Melphalan1件: Melphalan 💬--15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬
1238Memantine1件: Memantine1件: Memantine 💬5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬8件: 2, 6, 8, 13, 49, 127, 205, 206 💬
1239Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent)----1件: 13 💬
1240Menitorix----1件: 13 💬
1241Menveo9件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine,
Meningococcal polysaccharide vaccine group A,
Meningococcal polysaccharide vaccine group C,
Meningococcal polysaccharide vaccine group W-135,
Meningococcal polysaccharide vaccine group Y,
Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen,
Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen		2件: Meningococcal polysaccharide vaccine group A ,
Meningococcal polysaccharide vaccine group C 💬		--6件: 11, 13, 61, 62, 66, 222 💬
1242Mesenchymal stem cells----11件: 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299 💬
1243Mesenchymal stem cells (MSC)----3件: 2, 13, 96 💬
1244Mesenchymal stem cells (MSCs)----4件: 13, 36, 96, 97 💬
1245Mesenchymal stem/stromal cells----1件: 13 💬
1246Mesna1件: Coenzyme M---10件: 11, 13, 44, 45, 51, 60, 65, 85, 96, 164 💬
1247Metex----2件: 13, 46 💬
1248Metformin1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 💬
1249MetFORMIN 1000 Mg Oral Tablet1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
1250Metformin 500 Mg Oral Tablet, up to 4 tablets a day1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
1251Metformin and clemastine in combination2件: Clemastine,
Metformin		2件: Clemastine ,
Metformin 💬		3件: HRH1,
PRKAA1,
PRKAA2 💬		23件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Calcium signaling pathway, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Inflammatory mediator regulation of TRP channels, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬1件: 13 💬
1252Methelphenidate----1件: 13 💬
1253Methotrexat1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬4件: 13, 46, 50, 96 💬
1254Methotrexate1件: Methotrexate1件: Methotrexate 💬2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬38件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 💬
1255Methyl Prednisolonate----1件: 13 💬
1256Methyloprednisolone----1件: 13 💬
1257Methylphenidate1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬7件: 6, 13, 34, 84, 113, 179, 206 💬
1258METHYLPHENIDATE HYDROCHLORIDE1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 6, 13 💬
1259Methylphenidate modified release1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
1260Methylphenidate modified release 20 mg1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
1261Methylphenidate modified release 30 mg1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
1262Methylphenidate modified release 40 mg1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
1263Methylprednisolon1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬4件: 13, 14, 51, 66 💬
1264Methylprednisolon-21-hydrogensuccinat, Natriumsalz1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1265Methylprednisolone1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
1266Methylprednisolone (drug)1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1267Methylprednisolone 1250 mg/24h x3 days1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1268Methylprednisolone hemisuccinate2件: Methylprednisolone,
Methylprednisolone hemisuccinate		2件: Methylprednisolone ,
Methylprednisolone hemisuccinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1269Methylprednisolone IV1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1270Methylprednisolone PO1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1271METHYLPREDNISOLONE SODIUM HEMISUCCINATE1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 13, 97 💬
1272METHYLPREDNISOLONE SODIUM SUCCINATE2件: Methylprednisolone,
Methylprednisolone hemisuccinate		2件: Methylprednisolone ,
Methylprednisolone hemisuccinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬6件: 13, 46, 49, 50, 51, 211 💬
1273Methylprednisolone succinate2件: Methylprednisolone,
Methylprednisolone hemisuccinate		2件: Methylprednisolone ,
Methylprednisolone hemisuccinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1274METILPREDNISOLONE----6件: 11, 13, 53, 56, 63, 300 💬
1275Metilprednisolone sodio succinato----3件: 13, 14, 56 💬
1276Mg----5件: 6, 13, 51, 63, 111 💬
1277Microgynon----2件: 13, 51 💬
1278Microgynon®----1件: 13 💬
1279Micropirin----1件: 13 💬
1280Midazolam1件: Midazolam1件: Midazolam 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299 💬
1281Mild dose cannabis1件: Medical Cannabis---1件: 13 💬
1282Minocycline1件: Minocycline1件: Minocycline 💬--13件: 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬
1283Minocycline 100 mg Film-coated Tablets1件: Minocycline1件: Minocycline 💬--1件: 13 💬
1284Minocycline 100mg1件: Minocycline1件: Minocycline 💬--1件: 13 💬
1285Minocycline Hydrochloride1件: Minocycline1件: Minocycline 💬--4件: 13, 201, 206, 299 💬
1286Mirabegron1件: Mirabegron1件: Mirabegron 💬1件: ADRB3 💬8件: Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬4件: 6, 13, 53, 226 💬
1287MiRNA----1件: 13 💬
1288MIS416----1件: 13 💬
1289MitoQ----3件: 6, 13, 97 💬
1290Mitoquinone1件: Mitoquinone---1件: 13 💬
1291Mitoxantrone1件: Mitoxantrone1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
1292Mitoxantrone Hydrochloride Liposome Injection1件: Mitoxantrone1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
1293MK0812----2件: 13, 46 💬
1294MLN1202----1件: 13 💬
1295MMF----16件: 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 107, 162, 222, 224, 226, 299 💬
1296MODAFINIL1件: Modafinil1件: Modafinil 💬--4件: 6, 13, 49, 93 💬
1297Moderna mRNA-1273----7件: 13, 35, 46, 49, 50, 51, 107 💬
1298Moderna mRNA-1273, Bivalent----7件: 13, 35, 46, 49, 50, 51, 107 💬
1299MOG peptide----1件: 13 💬
1300Monoclonal antibody M-T412----1件: 13 💬
1301Monomethyl fumarate1件: Monomethyl fumarate1件: Monomethyl fumarate 💬--1件: 13 💬
1302Monomethyl fumarate 190 mg1件: Monomethyl fumarate1件: Monomethyl fumarate 💬--1件: 13 💬
1303Monovalent [B.1.351] CoV2 preS dTM-AS03----7件: 13, 35, 46, 49, 50, 51, 107 💬
1304Montelukast1件: Montelukast1件: Montelukast 💬1件: CYSLTR1 💬2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬8件: 6, 13, 46, 61, 63, 85, 98, 228 💬
1305MOR103----2件: 13, 46 💬
1306Most recent vaccine to seasonal influenza----1件: 13 💬
1307MPA----8件: 13, 35, 46, 49, 50, 51, 60, 107 💬
1308MRI contrast-enhancing preparations----1件: 13 💬
1309MSC2015----1件: 13 💬
1310MSC2304479A----1件: 13 💬
1311MSC2304480A----1件: 13 💬
1312MSC2304481A----1件: 13 💬
1313MSC2304482A----1件: 13 💬
1314MSC2358825A----1件: 13 💬
1315MSC2364447C----2件: 13, 49 💬
1316MSC2430913A or ONO-4641 (to be used as synonyms)----1件: 13 💬
1317MSC2491529A----1件: 13 💬
1318MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046)2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1319MSTC-001 (MS-STAT)----1件: 13 💬
1320MT-1303----3件: 13, 96, 97 💬
1321MT-1303 [0.1]----1件: 13 💬
1322MT-1303 [0.2]----1件: 13 💬
1323MT-1303 [0.4]----1件: 13 💬
1324MT-1303-FormA----1件: 13 💬
1325MT-1303-FormB----1件: 13 💬
1326MT-1303-High----1件: 13 💬
1327MT-1303-Low----1件: 13 💬
1328MT-1303-Middle----1件: 13 💬
1329MTX----14件: 13, 35, 40, 46, 49, 50, 51, 60, 84, 96, 97, 107, 162, 271 💬
1330Multiferon----1件: 13 💬
1331Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides)1件: Myelin basic protein---1件: 13 💬
1332Mutagrip----2件: 11, 13 💬
1333Mycophenolate1件: Mycophenolic acid1件: Mycophenolic acid 💬2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬36件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
1334Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬34件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
1335Mycophenolate mofetil (CellCept)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬2件: 11, 13 💬
1336Mycophenolate mofetil (MMF)2件: Mycophenolate mofetil,
Mycophenolic acid		2件: Mycophenolate mofetil ,
Mycophenolic acid 💬		2件: IMPDH1,
IMPDH2 💬		4件: Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬7件: 13, 49, 51, 60, 65, 66, 222 💬
1337Myelin1件: Myelin basic protein---1件: 13 💬
1338MYOBLOC1件: Botulinum toxin type B1件: Rimabotulinumtoxin B 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬1件: 13 💬
1339Méthylprednisolone----1件: 13 💬
1340Méthylprednisolone Mylan----1件: 13 💬
1341N-acetyl cysteine1件: Cysteine---6件: 13, 34, 85, 88, 296, 310 💬
1342N-Acetylcysteine1件: Acetylcysteine1件: Acetylcysteine 💬--13件: 6, 13, 19, 20, 21, 49, 58, 85, 90, 111, 164, 299, 337 💬
1343N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine----1件: 13 💬
1344N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM1971件: Corynebacterium diphtheriae CRM197 protein---1件: 13 💬
1345N.a.----10件: 3, 6, 8, 13, 46, 96, 97, 240, 256, 271 💬
1346N02BG10----1件: 13 💬
1347N03AX12----1件: 13 💬
1348N06DX01----1件: 13 💬
1349Na18F----1件: 13 💬
1350NABILONE1件: Nabilone1件: Nabilone 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬3件: 6, 13, 127 💬
1351Nabiximols1件: Nabiximols1件: Nabiximols 💬--1件: 13 💬
1352Nabiximols - Sativex3件: Cannabidiol,
Dronabinol,
Nabiximols		3件: Dronabinol ,
Nabiximols ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1353Naltrexone1件: Naltrexone1件: Naltrexone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬12件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
1354Namisol----2件: 13, 298 💬
1355Nanocort----3件: 13, 46, 97 💬
1356Nanocurcumin----2件: 13, 271 💬
1357Naproxen1件: Naproxen1件: Naproxen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬4件: 13, 46, 107, 271 💬
1358NATALIZUMAB1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬5件: 13, 15, 25, 46, 96 💬
1359Natalizumab (BG00002)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1360Natalizumab (NTZ)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1361Natalizumab (Tysabri)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1362Natalizumab 300 MG in 15 ML Injection1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1363Natalizumab for IV Infusion1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1364Natalizumab for Subcutaneous Injection1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1365Natalizumab Injection [Tysabri]1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1366Natalizumab IV1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1367Natalizumab SC1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1368Natalizumab treatment1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1369NBI-5788----1件: 13 💬
1370NBT-NM108 (60 g/day)----1件: 13 💬
1371Nd----6件: 2, 6, 13, 46, 51, 97 💬
1372Nebido----1件: 13 💬
1373Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection3件: Testosterone,
Testosterone undecanoate,
Undecanoic acid		2件: Testosterone ,
Testosterone undecanoate 💬		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬1件: 13 💬
1374Necator americanus----1件: 13 💬
1375NeoRecormon1件: Erythropoietin---2件: 13, 18 💬
1376Neramexane1件: Neramexane---1件: 13 💬
1377Neramexane mesylate1件: Neramexane---1件: 13 💬
1378Nerispirdine1件: Nerispirdine---1件: 13 💬
1379Nerispirdine (HP184)1件: Nerispirdine---1件: 13 💬
1380Nerispirdine hydrochloride1件: Nerispirdine---1件: 13 💬
1381NEUPOGEN1件: Filgrastim1件: Filgrastim 💬1件: CSF3R 💬5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬4件: 13, 28, 51, 285 💬
1382NEUROASPIS PLP10®----1件: 13 💬
1383NEURONTIN1件: Gabapentin1件: Gabapentin 💬5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
1384Neurontin 300 mg hard capsule1件: Gabapentin1件: Gabapentin 💬5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬		9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
1385NeuroVax1件: NeuroVax---1件: 13 💬
1386NeuroVax 300ug/mL Dose for IM Injection1件: NeuroVax---1件: 13 💬
1387New Formulation of rebif - human interferon beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1388Nicotinamid riboside----1件: 13 💬
1389NICOTINE1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬3件: 6, 13, 84 💬
1390Nicotine dependence1件: Nicotine1件: Nicotine 💬16件: CHRNA1,
CHRNA10,
CHRNA2,
CHRNA3,
CHRNA4,
CHRNA5,
CHRNA6,
CHRNA7,
CHRNA9,
CHRNB1,
CHRNB2,
CHRNB3,
CHRNB4,
CHRND,
CHRNE,
CHRNG 💬		8件: Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Virion - Lyssavirus 💬1件: 13 💬
1391Ninlaro1件: Ixazomib1件: Ixazomib 💬1件: PSMB5 💬8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬2件: 13, 61 💬
1392Nitrofurantoin1件: Nitrofurantoin1件: Nitrofurantoin 💬--1件: 13 💬
1393Nivolumab1件: Nivolumab1件: Nivolumab 💬1件: PDCD1 💬3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
1394Nomegestrol1件: Nomegestrol1件: Nomegestrol 💬1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
1395Nomegestrol acetate3件: Acetate,
Nomegestrol,
Nomegestrol acetate		2件: Nomegestrol ,
Nomegestrol acetate 💬		1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬1件: 13 💬
1396Non applicabile----4件: 13, 49, 51, 256 💬
1397Non-pegylated interferon----1件: 13 💬
1398Norethindrone1件: Norethisterone1件: Norethindrone 💬1件: PGR 💬5件: Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬4件: 13, 46, 49, 299 💬
1399Normal Saline----18件: 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 💬
1400Normal Saline for Injection----1件: 13 💬
1401Novantrone1件: Mitoxantrone1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
1402NOVANTRONE*INF 2MG/ML 5ML1件: Mitoxantrone1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
1403Novartis Pharmaceuticals Corporation----1件: 13 💬
1404NOVATREX----1件: 13 💬
1405NPB-01----3件: 13, 14, 162 💬
1406NT-KO-003----1件: 13 💬
1407NU100----1件: 13 💬
1408Null----16件: 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬
1409NurOwn (MSC-NTF cells)----2件: 2, 13 💬
1410NVF233----1件: 13 💬
1411OCH-NCNP1----1件: 13 💬
1412Oclelizumab----1件: 13 💬
1413OCR----1件: 13 💬
1414OCRELIZUMAB1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬3件: 13, 46, 49 💬
1415Ocrelizumab (CinnaGen, Iran)1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1416Ocrelizumab (Roche, Switzerland)1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1417Ocrelizumab 300 mg1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1418Ocrelizumab 300mg1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1419Ocrelizumab 300mg /10ml1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1420Ocrelizumab 300mg/10 ml1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1421Ocrelizumab 300mg/10ml1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1422Ocrelizumab 600 mg1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1423Ocrelizumab at home1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1424Ocrelizumab Dose 11件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1425Ocrelizumab Dose 2 and Dose 31件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1426Ocrelizumab IV1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1427Ocrelizumab SC1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1428OCREVUS1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1429Ocrevus 300 mg, solution à diluer pour perfusion1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1430Ocrrelizumab 300 mg----1件: 13 💬
1431Octagam----2件: 13, 65 💬
1432Octagam 5%----2件: 13, 65 💬
1433Octagam 50 mg/ml1件: Human immunoglobulin G---1件: 13 💬
1434Ocufolin----1件: 13 💬
1435OFATUMUMAB1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬3件: 13, 35, 46 💬
1436Ofatumumab 1001件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1437Ofatumumab 3001件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1438Ofatumumab 30mg1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1439Ofatumumab 3mg1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1440Ofatumumab 60mg1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1441Ofatumumab 7001件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1442Ofatumumab subcutaneous injection1件: Ofatumumab1件: Ofatumumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1443Oleic Acid1件: Oleic Acid1件: Oleic acid 💬--2件: 13, 299 💬
1444Oleovit D3 14.400 IU/ml oral drops, solution----1件: 13 💬
1445Olesoxime1件: Olesoxime1件: Olesoxime 💬--3件: 2, 3, 13 💬
1446Olesoxime (TRO19622)1件: Olesoxime1件: Olesoxime 💬--1件: 13 💬
1447Olive1件: Olea europaea leaf---5件: 13, 35, 49, 53, 162 💬
1448Olive oil2件: Olea europaea leaf,
Olive oil		1件: Olive oil 💬--5件: 13, 35, 49, 53, 162 💬
1449OMB 157----1件: 13 💬
1450OMB157----1件: 13 💬
1451OMB157G----1件: 13 💬
1452Omega 3----3件: 13, 53, 299 💬
1453Omega-31件: Omega-3 fatty acids---7件: 13, 46, 49, 66, 79, 96, 299 💬
1454Omega-3 fatty acids1件: Omega-3 fatty acids---2件: 13, 79 💬
1455OnabotulinumtoxinA1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬4件: 6, 13, 149, 226 💬
1456ONO-4641----1件: 13 💬
1457ONO-4641/ MSC2430913A----1件: 13 💬
1458ONO-4641/MSC2430913A----1件: 13 💬
1459Opicinumab1件: Opicinumab1件: Opicinumab 💬1件: LINGO1 💬-1件: 13 💬
1460Oral corticosteroids----5件: 13, 46, 97, 171, 251 💬
1461Oral lipoic acid (LA)1件: Lipoic acid---1件: 13 💬
1462Oral Methylprednisolone 625 mg/24h x3 days1件: Methylprednisolone1件: Methylprednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬1件: 13 💬
1463Oral THC----1件: 13 💬
1464Orelabrutinib1件: Orelabrutinib1件: Orelabrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬4件: 13, 49, 61, 63 💬
1465ORY2001----1件: 13 💬
1466OS440----1件: 13 💬
1467Other analgesics and antipyretics----1件: 13 💬
1468Other disease-modifying therapy----1件: 13 💬
1469Other H1 antagonist----1件: 13 💬
1470OTHER NERVOUS SYSTEM DRUGS----2件: 6, 13 💬
1471OVASTAT1件: Treosulfan1件: Treosulfan 💬--2件: 13, 65 💬
1472Ovastat 10001件: Treosulfan1件: Treosulfan 💬--2件: 13, 65 💬
1473Ovastat 50001件: Treosulfan1件: Treosulfan 💬--2件: 13, 65 💬
1474Oxcarbazepine1件: Oxcarbazepine1件: Oxcarbazepine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
1475Oxiklorin----2件: 13, 46 💬
1476Oxine1件: Oxyquinoline1件: Oxyquinoline 💬--1件: 13 💬
1477Oxybutynin1件: Oxybutynin1件: Oxybutynin 💬5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬3件: 6, 13, 53 💬
1478Oxybutynin hydrochloride1件: Oxybutynin1件: Oxybutynin 💬5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬2件: 6, 13 💬
1479Oxycodone1件: Oxycodone1件: Oxycodone 💬3件: OPRD1,
OPRK1,
OPRM1 💬		5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬5件: 6, 13, 70, 226, 298 💬
1480Ozanimod1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 96, 97 💬
1481Ozanimod 0.5 mg1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1482Ozanimod 1 mg1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1483Ozanimod HCI1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1484Ozanimod HCL1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 97 💬
1485Ozanimod hydrochloride1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 13, 96, 97 💬
1486Palifermin1件: Palifermin1件: Palifermin 💬1件: FGFR2 💬13件: Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬5件: 13, 36, 38, 39, 65 💬
1487Pantoprazole1件: Pantoprazole1件: Pantoprazole 💬2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬2件: 13, 65 💬
1488PARACETAMOL1件: Acetaminophen1件: Acetaminophen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬6件: 3, 6, 13, 35, 46, 49 💬
1489Paracetamolo 500 mg----1件: 13 💬
1490Paroxetine1件: Paroxetine1件: Paroxetine 💬1件: SLC6A4 💬2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 6, 13, 46, 85 💬
1491Part A: 100 mg/mL GSK2618960----1件: 13 💬
1492Part B: Dose of GSK2618960 decided from Part A----1件: 13 💬
1493Part C: Dose of GSK2618960 decided from Part A and B----1件: 13 💬
1494PB006----1件: 13 💬
1495PCV----1件: 13 💬
1496PEG----15件: 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337 💬
1497PEG-liposomal Prednisolone Sodium Phosphate2件: Phosphate ion,
Prednisolone		1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬2件: 13, 97 💬
1498PEGINTERFERON BETA-1A1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1499Peginterferone beta 1a----1件: 13 💬
1500PEGINTERFERONE BETA-1A----1件: 13 💬
1501PEGINTERFERONE LAMBDA-1A----1件: 13 💬
1502PEGylated Intereron Beta-1a----1件: 13 💬
1503PEGylated Interferon Beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1504Pending----6件: 13, 19, 96, 97, 113, 302 💬
1505Perfusion of treatment Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1506Perfusion of treatment Rituximab1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1507Personalized extended interval dosing of natalizumab1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1508Pertussis vaccine1件: Pertussis vaccine1件: Pertussis vaccine 💬--2件: 13, 46 💬
1509PET with 11C-Flumazenil1件: Flumazenil1件: Flumazenil 💬16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13 💬
1510PF-06342674 0.25 mg/kg----1件: 13 💬
1511PF-06342674 1.5 mg/kg----1件: 13 💬
1512PF-06342674 6.0 mg/kg----1件: 13 💬
1513Phase 2----1件: 13 💬
1514Phase 3----1件: 13 💬
1515PHENYLCYCLOPROPYLAMINE DERIVATIVES AND DUAL LSD1/MAO-B (LYSINE-SPECIFIC DEMETHYLASE 1 AND MONOAMINE OXIDASE-B) INHIBITOR1件: Lysine1件: Lysine 💬--1件: 13 💬
1516Phenytoin1件: Phenytoin1件: Phenytoin 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
1517Phosphate1件: Phosphate ion---32件: 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 💬
1518PI-2301----1件: 13 💬
1519Pioglitazone1件: Pioglitazone1件: Pioglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
1520PIPE-307----1件: 13 💬
1521Pirfenidone1件: Pirfenidone1件: Pirfenidone 💬6件: CCL2,
IL10,
IL1A,
IL1B,
IL6,
TNF 💬		84件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1522PIXANTRONE1件: Pixantrone1件: Pixantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬2件: 11, 13 💬
1523PL 04515/0127----1件: 13 💬
1524PL 12762/0049----1件: 13 💬
1525Placebo----28件: 3, 5, 6, 11, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬
1526Platelet transfusion----1件: 13 💬
1527Platform----1件: 13 💬
1528PLEDIGRY----1件: 13 💬
1529Plegridy1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1530Plegridy (peginterferon beta-1a), Biogen Idec Ltd1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1531PLEGRIDY - 125 MCG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - PENNA PRERIEMPITA - 0,5 ML - 6 PENNE PRERIEMPITE1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1532Plegridy 125 micrograms1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1533Plegridy 63 micrograms1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1534Pleneva TM BGC20-0134----1件: 13 💬
1535Plovamer acetate1件: Acetate---1件: 13 💬
1536Plovamer acetate 0.5 milligram (mg)1件: Acetate---1件: 13 💬
1537Plovamer acetate 10 mg1件: Acetate---1件: 13 💬
1538Plovamer acetate 20 mg1件: Acetate---1件: 13 💬
1539Plovamer acetate 3 mg1件: Acetate---1件: 13 💬
1540PLP----1件: 13 💬
1541PLP peptide----1件: 13 💬
1542PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE (13-VALENT, ADSORBED)----2件: 13, 14 💬
1543Pneumococcal polysaccharide vaccine----3件: 13, 46, 222 💬
1544Pneumovax II----1件: 13 💬
1545PNU-215062 sodium salt----1件: 13 💬
1546PO----1件: 13 💬
1547Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.----1件: 13 💬
1548Polyphenon E----2件: 13, 36 💬
1549PONESIMOD1件: Ponesimod1件: Ponesimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1550Ponesimod 10 mg1件: Ponesimod1件: Ponesimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1551Ponesimod 20 mg1件: Ponesimod1件: Ponesimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1552Ponesimod 40 mg1件: Ponesimod1件: Ponesimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1553Ponvory1件: Ponesimod1件: Ponesimod 💬1件: S1PR1 💬3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1554Pravastatin1件: Pravastatin1件: Pravastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
1555PRD806998----1件: 13 💬
1556Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)----1件: 13 💬
1557PREDNISOLONE1件: Prednisolone1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
1558PREDNISOLONE SODIUM PHOSPHATE2件: Phosphate ion,
Prednisolone		1件: Prednisolone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬3件: 3, 13, 97 💬
1559Prednisone1件: Prednisone1件: Prednisone 💬1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
1560Pregabalin1件: Pregabalin1件: Pregabalin 💬4件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬		7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬5件: 13, 36, 46, 70, 298 💬
1561Prepulsid----1件: 13 💬
1562Prevenar 1312件: Streptococcus pneumoniae type 1 capsular polysaccharide antigen,
Streptococcus pneumoniae type 14 capsular polysaccharide antigen,
Streptococcus pneumoniae type 18c capsular polysaccharide antigen,
Streptococcus pneumoniae type 19a capsular polysaccharide antigen,
Streptococcus pneumoniae type 19f capsular polysaccharide antigen,
Streptococcus pneumoniae type 23f capsular polysaccharide antigen,
Streptococcus pneumoniae type 3 capsular polysaccharide antigen,
Streptococcus pneumoniae type 4 capsular polysaccharide antigen,
Streptococcus pneumoniae type 5 capsular polysaccharide antigen,
Streptococcus pneumoniae type 6b capsular polysaccharide antigen,
Streptococcus pneumoniae type 7f capsular polysaccharide antigen,
Streptococcus pneumoniae type 9v capsular polysaccharide antigen		---5件: 13, 14, 46, 96, 222 💬
1563PRN2246----2件: 11, 13 💬
1564Probiotics (Visbiome®)----1件: 13 💬
1565Prohance (Gadoteridol)1件: Gadoteridol1件: Gadoteridol 💬--1件: 13 💬
1566Prolonged-release Fampridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
1567Prophylactic vaccine (tetanus, diphtheria, pertussis, poliomyelitis, influenza, hepatitis A, hepatitis B, tick-borne encephalitis, meningococcal, pneumococcal)----1件: 13 💬
1568Provigil1件: Modafinil1件: Modafinil 💬--2件: 13, 113 💬
1569Provigil (modafinil)1件: Modafinil1件: Modafinil 💬--1件: 13 💬
1570PRUCALOPRIDE1件: Prucalopride1件: Prucalopride 💬1件: HTR4 💬4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬3件: 13, 51, 96 💬
1571PTL201----1件: 13 💬
1572Quadrivalent influenza vaccine----1件: 13 💬
1573Quality of life----1件: 13 💬
1574Quetiapine1件: Quetiapine1件: Quetiapine 💬2件: DRD2,
HTR2A 💬		11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬2件: 6, 13 💬
1575Quinidina1件: Quinidine1件: Quinidine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
1576Quinidina sulfato1件: Quinidine1件: Quinidine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
1577Quinidine1件: Quinidine1件: Quinidine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬3件: 2, 8, 13 💬
1578Quinidine Sulfate2件: Quinidine,
Sulfate ion		1件: Quinidine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
1579R lipoic acid1件: Lipoic acid---1件: 13 💬
1580RA15804589, C19061501-F, DNL788, DN2489, DN0002489----2件: 2, 13 💬
1581Rabbit1件: Rabbit---8件: 11, 13, 49, 51, 60, 65, 96, 285 💬
1582Rabbit anti-human thymocyte immunoglobulin2件: Antithymocyte immunoglobulin (rabbit),
Rabbit		---2件: 13, 96 💬
1583RABBIT HUMAN T LYMPHOCYTE IMMUNOGLOBULIN1件: Rabbit---2件: 13, 60 💬
1584Ralenova----1件: 13 💬
1585Raltegravir1件: Raltegravir1件: Raltegravir 💬--4件: 13, 26, 93, 265 💬
1586Ramatroban1件: Ramatroban1件: Ramatroban 💬2件: PTGDR,
TBXA2R 💬		3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬1件: 13 💬
1587Ranitidine1件: Ranitidine1件: Ranitidine 💬1件: HRH2 💬3件: Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬2件: 13, 65 💬
1588Raptiva1件: Efalizumab1件: Efalizumab 💬1件: ITGAL 💬12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 💬
1589Raptiva 100 mg/ml powder and solvent for solution for injection1件: Efalizumab1件: Efalizumab 💬1件: ITGAL 💬12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬7件: 11, 13, 46, 53, 61, 95, 96 💬
1590RATG1件: Antithymocyte immunoglobulin (rabbit)---4件: 13, 51, 60, 285 💬
1591RAVULIZUMAB1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 2, 11, 13, 50, 62, 66, 109 💬
1592RC18 160 mg----2件: 13, 53 💬
1593RC18 160mg----3件: 11, 13, 66 💬
1594RC18 240mg----2件: 13, 66 💬
1595REBIF1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1596Rebif (IFN beta-1a subcutaneous three times per week)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1597Rebif (IFN ß-1a subcutaneous three times per week)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1598Rebif (interferon beta 1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1599Rebif (Interferon beta-1a)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1600Rebif (interferon beta-1a), Merck Serono Europe Ltd2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1601REBIF - 44 MCG(12 MILIONI UI) -SOLUZ INIETTABILE- USO SOTTOCUTANEO-PENNA PRERIEMPITA 0.5 ML (24 MILIONI UI/ML)12 PENNE PRERIEMPITE1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1602Rebif 221件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1603Rebif 22 micrograms1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1604Rebif 22 y 44 mcg1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1605Rebif 22®1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1606Rebif 441件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1607Rebif 44 microgrammi/0.5ml soluzione iniettabile in cartuccia1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1608REBIF 44 microgramos solución inyectable1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1609REBIF 44 microgramos solución inyectable en jeringa precargada1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1610Rebif 44 micrograms1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1611Rebif 44 micrograms solution for injection1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1612Rebif 44 micrograms solution for injection in pre-filled syringe1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1613Rebif 44 µg1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1614Rebif 44®1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1615Rebif 8,8 µg, Rebif 22µg1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1616Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1617Rebif 8.8 micrograms and 22 micrograms solution for injection in pre-filled syringe initiation pack.1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1618Rebif New Formulation + ibuprofen PRN1件: Ibuprofen1件: Ibuprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
1619Rebif New Formulation + prophylactic Ibuprofen1件: Ibuprofen1件: Ibuprofen 💬2件: PTGS1,
PTGS2 💬		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 13 💬
1620Rebif New Formulation 44mcg multidose cartridge1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1621Rebif New Formulation Non Titrated1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1622Rebif New Formulation Titrated1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1623REBIF SC 12SIR 12000000UI44MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1624REBIF SC 12SIR 6000000UI 22MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1625REBIF*SC 12SIR 12000000UI44MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1626REBIF*SC 12SIR 6000000UI 22MCG1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1627Rebif®1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1628Rebif® (clone 484-39)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1629Rebif® New Formulation1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1630Rebif® New Formulation (IFN-beta-1a, RNF)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1631Rebif® new formulation (RNF)1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1632Rebif® New Formulation (RNF) using RebiSmartTM1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1633Recombinant human alpha B-crystallin----1件: 13 💬
1634Recombinant Human Erythropoietin1件: Erythropoietin---1件: 13 💬
1635Recombinant human IFN beta----1件: 13 💬
1636Recombinant human interferon beta1件: Human interferon beta---1件: 13 💬
1637Recombinant humanized anti-alpha 4 integrin antibody----1件: 13 💬
1638Recombinant humanized anti-CD20 monoclonal antibody----1件: 13 💬
1639RECOMBINANT INTERFERON BE----1件: 13 💬
1640RECOMBINANT INTERFERON BETA-1B2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1641RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN2件: Iron polymaltose,
Lactobacillus casei		1件: Lactobacillus casei 💬--2件: 11, 13 💬
1642Recombinant zoster vaccine----2件: 13, 49 💬
1643Release1件: Manganese citrate---12件: 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 💬
1644Remibrutinib1件: Remibrutinib1件: Remibrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬2件: 13, 53 💬
1645Repository corticotropin injection1件: Corticotropin1件: Corticotropin 💬1件: MC2R 💬5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 2, 13, 46, 84, 222 💬
1646REVAXIS----1件: 13 💬
1647RG2077 (CTLA4-IgG4m)----1件: 13 💬
1648RHB-104----2件: 13, 96 💬
1649RhEPO----1件: 13 💬
1650RhIFN beta-1b----1件: 13 💬
1651RhIGF-1 (CEP-151)----1件: 13 💬
1652RHIgM22----1件: 13 💬
1653RhuMAb 2H71件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬3件: 13, 46, 49 💬
1654RhumAb to Il-17A (IgG1-k-class)----4件: 13, 46, 56, 96 💬
1655RhumAb to IL-17A igG1-k-class----1件: 13 💬
1656RHuPH20----2件: 13, 14 💬
1657Rifampin1件: Rifampicin1件: Rifampin 💬--5件: 6, 13, 84, 86, 299 💬
1658RILUTEK1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬3件: 2, 13, 203 💬
1659RILUZOLE1件: Riluzole1件: Riluzole 💬14件: GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		23件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬9件: 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
1660RIPK1 inhibitor----1件: 13 💬
1661Ritalin1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬2件: 6, 13 💬
1662Ritalin LA 20mg capsules1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
1663Ritalin LA 30mg capsules1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
1664Ritalin LA 40mg capsules1件: Methylphenidate1件: Methylphenidate 💬2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 13 💬
1665RITUXIMAB1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬48件: 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
1666Rituximab Infusion1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬2件: 13, 222 💬
1667Rituximab IT1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1668Rituximab IV1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1669Rituximab konsentrat til infusjonsvaeske oppløsning 10 mg/ml1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1670Rivastigmin----1件: 13 💬
1671RIVASTIGMINE1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬3件: 5, 6, 13 💬
1672Rivastigmine transdermal patch1件: Rivastigmine1件: Rivastigmine 💬1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬2件: 6, 13 💬
1673RNF----1件: 13 💬
1674RNS60----2件: 2, 13 💬
1675RNS60 125 ml----1件: 13 💬
1676RNS60 250 ml----1件: 13 💬
1677Ro 496-4913/F03----2件: 13, 46 💬
1678Ro 496-4913/F07----1件: 13 💬
1679Ro 533-3787/F01- 06----1件: 13 💬
1680RO0506997----2件: 13, 46 💬
1681RO4964913----1件: 13 💬
1682RO4964913 F07----1件: 13 💬
1683RO4964913/F03----1件: 13 💬
1684RO4964913/F07----1件: 13 💬
1685RO4964913/F07-01----1件: 13 💬
1686RO5333787----2件: 11, 13 💬
1687RO7010939----2件: 13, 46 💬
1688RO7121932----1件: 13 💬
1689Rolipram1件: Rolipram1件: Rolipram 💬4件: PDE4A,
PDE4B,
PDE4C,
PDE4D 💬		5件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬2件: 8, 13 💬
1690RPC-1063----1件: 13 💬
1691RPC1063----3件: 13, 96, 97 💬
1692RTL1000 (recombinant T cell receptor ligand)----1件: 13 💬
1693Ruxience1件: Rituximab1件: Rituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1694S-Warfarin2件: (S)-Warfarin,
Warfarin		1件: Warfarin 💬2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 13 💬
1695SA237----1件: 13 💬
1696Saline1件: Sodium chloride1件: Sodium chloride 💬--10件: 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 💬
1697Sapelizumab1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1698Sapelizumab (p-INN)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1699SAR339658----2件: 13, 97 💬
1700SAR441344----3件: 13, 49, 53 💬
1701SAR441344 IV----2件: 13, 49 💬
1702SAR441344 SC----2件: 13, 49 💬
1703SAR442168----2件: 11, 13 💬
1704SAR443820----2件: 2, 13 💬
1705SARS-COV-2 mRNA Vaccine2件: CVnCoV,
SARS-CoV-2 mRNA vaccine		---1件: 13 💬
1706Sativex2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬2件: 2, 13 💬
1707Sativex 2,7mg/2,5 mg Solucion para pulverizacion bucal2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1708Sativex Oromucosal Spray2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1709Sativex Oromucosal Spray (non-marketed)2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1710Sativex®2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1711SATRALIZUMAB1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬3件: 11, 13, 86 💬
1712Satralizumab (120 mg/PFS with NSD)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1713Satralizumab (120 mg/vial)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1714Satralizumab (120mg/vial)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1715Satralizumab (r-INN)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1716Satralizumab (RO5333787/Enspryng /SA237)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1717Satralizumab (RO5333787/Enspryng/SA237)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1718Satralizumab (RO5333787/SA237)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1719Satralizumab 120 mg1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1720Satrazlizumab (RO5333787/ Enspryng /SA237)1件: Satralizumab1件: Satralizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1721SB-683699----1件: 13 💬
1722SB683699----1件: 13 💬
1723SC interferon beta-1a2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1724SC interferon beta-1b2件: Human interferon beta,
Interferon beta-1b		1件: Interferon beta-1b 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1725SC Peginterferon beta-1a1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1726SCLEROLYM----1件: 13 💬
1727SCM----1件: 13 💬
1728SCM-010----1件: 13 💬
1729Seasonal influenza vaccine----2件: 13, 46 💬
1730Seasonal Quadrivalent influenza vaccine----1件: 13 💬
1731Second-generation fumaric acid1件: Fumaric acid1件: Fumaric acid 💬--1件: 13 💬
1732SECUKINUMAB1件: Secukinumab1件: Secukinumab 💬1件: IL17A 💬6件: Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Rheumatoid arthritis, Th17 cell differentiation 💬8件: 13, 37, 41, 46, 107, 160, 269, 271 💬
1733See Intervention Description)----1件: 13 💬
1734Selenium1件: Selenium---4件: 13, 96, 278, 298 💬
1735Sendoxan----2件: 13, 43 💬
1736Sendoxane----1件: 13 💬
1737Serum containing Avonex1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1738Serum Free Avonex1件: Interferon beta-1a1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1739SH U 555 C----1件: 13 💬
1740Short-course Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1741Silodyx1件: Silodosin1件: Silodosin 💬1件: ADRA1A 💬7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 13 💬
1742Simethicone1件: Simethicone1件: Simethicone 💬--2件: 13, 96 💬
1743SimvaHEXAL® 40 mg Filmtabletten----1件: 13 💬
1744Simvastatin1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
1745Simvastatin 40 mg film-coated tablets1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
1746Simvastatin Alternova1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
1747Simvastatin in relapsing remitting multiple sclerosis1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
1748Simvastatina1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
1749Simvastatina Sandoz 40 mg comprimidos recubiertos con película EFG1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
1750Simvastatine1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 6, 13, 288 💬
1751Simvastatine Sandoz 40 mg filmomhulde tabletten1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
1752Simvastatine Sandoz 40mg deelbare filmomhulde tabletten1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
1753Sinvastatina Sandoz 40 mg comprimidos revestidos por película----1件: 13 💬
1754Siponimob----1件: 13 💬
1755SIPONIMOD1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 50 💬
1756Siponimod 0,25 mg1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1757Siponimod 0.25 mg tablet1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 50 💬
1758Siponimod 0.5 mg tablet1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 50 💬
1759Siponimod 1 mg1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1760Siponimod 1 mg tablet1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 50 💬
1761Siponimod 2 mg1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1762Siponimod 2 mg tablet1件: Siponimod1件: Siponimod 💬2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬2件: 13, 50 💬
1763SIPONIMOD FUMARIC ACID2件: Fumaric acid,
Siponimod		2件: Fumaric acid ,
Siponimod 💬		2件: S1PR1,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1764Sirolimus1件: Sirolimus1件: Sirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬35件: 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 98, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 300, 331 💬
1765Sivatin----1件: 13 💬
1766Sivatin 40 mg film-coated tablets----1件: 13 💬
1767Sivelestat1件: Sivelestat1件: Sivelestat 💬1件: ELANE 💬3件: Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬3件: 13, 85, 96 💬
1768SMderpept----1件: 13 💬
1769Smoked Cannabis1件: Medical Cannabis---1件: 13 💬
1770Sodium chlorid----1件: 13 💬
1771Sodium chloride2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--20件: 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬
1772Sodium Chloride solution2件: Chloride ion,
Sodium chloride		1件: Sodium chloride 💬--4件: 11, 13, 51, 228 💬
1773Solifenacin1件: Solifenacin1件: Solifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬3件: 6, 13, 53 💬
1774Solifenacin Succinate1件: Solifenacin1件: Solifenacin 💬1件: CHRM3 💬11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬1件: 13 💬
1775SOLIRIS1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 11, 13, 14, 61, 62, 109, 222 💬
1776SOLIRIS - 300 MG CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 30 ML (10 MG/ML)1件: Eculizumab1件: Eculizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 13, 62, 109 💬
1777SOLU MEDROL - 125 MG/2 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE A DOPPIA CAMERA DA 125 MG/2 ML----3件: 13, 14, 53 💬
1778Solu-Medrol2件: Methylprednisolone,
Methylprednisolone hemisuccinate		2件: Methylprednisolone ,
Methylprednisolone hemisuccinate 💬		1件: NR3C1 💬1件: Neuroactive ligand-receptor interaction 💬7件: 13, 49, 50, 51, 53, 97, 211 💬
1779SOLU-MODERIN 1 g----1件: 13 💬
1780SoluMedrol----1件: 13 💬
1781Solumedrol IM 125mg/2ml----1件: 13 💬
1782Somatorelin1件: Somatorelin1件: Somatorelin 💬1件: GHRHR 💬2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬2件: 13, 78 💬
1783SPARC0921----1件: 13 💬
1784Spikevax1件: Moderna COVID-19 Vaccine1件: Elasomeran 💬--1件: 13 💬
1785Spiropent----2件: 6, 13 💬
1786SR-fampridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
1787Ss-interferon----1件: 13 💬
1788Standard gadolinium contrast1件: Gadolinium---1件: 13 💬
1789Standard interval dosing----1件: 13 💬
1790Standard MS DMT----1件: 13 💬
1791Standard MS DMTs----1件: 13 💬
1792Standard of Care----8件: 6, 13, 49, 51, 63, 64, 79, 171 💬
1793Standard treatment with a conventional drug----1件: 13 💬
1794Standardized cannabis extract1件: Medical Cannabis---1件: 13 💬
1795Statin----1件: 13 💬
1796Stem Cell Transplantation----10件: 13, 19, 20, 46, 65, 90, 125, 164, 234, 326 💬
1797Study Drug----2件: 6, 13 💬
1798SUB0750MIG----1件: 13 💬
1799SUB175614----1件: 13 💬
1800SUB22282----1件: 13 💬
1801Sublingual tizanidine 12 mg1件: Tizanidine1件: Tizanidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
1802Sulfate1件: Sulfate ion---27件: 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 💬
1803Sunphenon----2件: 13, 113 💬
1804Sunphenon EGCG1件: Epigallocatechin gallate---3件: 13, 17, 113 💬
1805Sunphenon EGCg TM----1件: 13 💬
1806Suspension media----1件: 13 💬
1807Sustained-release oral dalfampridine1件: Dalfampridine1件: Dalfampridine 💬4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
1808Suvorexant1件: Suvorexant1件: Suvorexant 💬2件: HCRTR1,
HCRTR2 💬		1件: Neuroactive ligand-receptor interaction 💬3件: 5, 6, 13 💬
1809T cell vaccination----1件: 13 💬
1810T-Cell Vaccination----1件: 13 💬
1811Tachipirina----2件: 13, 53 💬
1812TACHIPIRINA - 500 MG COMPRESSE20 COMPRESSE----2件: 13, 53 💬
1813Tachipirina CPR 500mg----1件: 13 💬
1814TACI-Fc51件: Atacicept1件: Atacicept 💬2件: TNFSF13,
TNFSF13B 💬		4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 46, 49 💬
1815Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬		5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬		33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬34件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 💬
1816Tamsulosin1件: Tamsulosin1件: Tamsulosin 💬3件: ADRA1A,
ADRA1B,
ADRA1D 💬		7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 13 💬
1817Tanakan1件: Ginkgo biloba---1件: 13 💬
1818Tarenflurbil1件: Tarenflurbil1件: Tarenflurbil 💬4件: APH1A,
NCSTN,
PSEN1,
PSENEN 💬		6件: Alzheimer disease, Human papillomavirus infection, Neurotrophin signaling pathway, Notch signaling pathway, Pathways of neurodegeneration - multiple diseases, Wnt signaling pathway 💬1件: 13 💬
1819Targretin1件: Bexarotene1件: Bexarotene 💬3件: RXRA,
RXRB,
RXRG 💬		17件: Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬1件: 13 💬
1820Tcelna----1件: 13 💬
1821TECFIDERA1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
1822Tecfidera (BG00012)1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
1823Tecfidera (BG12)----1件: 13 💬
1824TECFIDERA - 240 MG - CAPSULA RIGIDA GASTRORESISTENTE - USO ORALE - BLISTER (PVC/PE/PVDC-PVC ALLUMINIO) - 56 CAPSULE----1件: 13 💬
1825Tecfidera®1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
1826Tecfidera® 120 mg1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
1827Tecfidera® 120mg magensaftresistente Hartkapseln1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
1828Tecfidera® 240 mg1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
1829Tecfidera® 240mg magensaftresistente Hartkapseln1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
1830Tecifdera (dimethyl fumarate)1件: Dimethyl fumarate1件: Dimethyl fumarate 💬1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13 💬
1831TEMELIMAB1件: Temelimab---1件: 13 💬
1832Temsirolimus1件: Temsirolimus1件: Temsirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 13 💬
1833Temsirolimus Tablets1件: Temsirolimus1件: Temsirolimus 💬1件: MTOR 💬51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 13 💬
1834Tenofovir2件: Tenofovir,
Tenofovir disoproxil		1件: Tenofovir 💬--6件: 2, 13, 25, 93, 265, 325 💬
1835Tenofovir alafenamide2件: Tenofovir,
Tenofovir alafenamide		2件: Tenofovir ,
Tenofovir alafenamide 💬		--2件: 2, 13 💬
1836TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY]2件: Tenofovir,
Tenofovir alafenamide		2件: Tenofovir ,
Tenofovir alafenamide 💬		--1件: 13 💬
1837TERIFLUNOMIDE1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬3件: 13, 25, 26 💬
1838Teriflunomide (HMR1726)1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
1839Teriflunomide 14 MG1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
1840Teriflunomide 14 MG Oral Tablet [Aubagio]1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
1841Teriflunomide capsule1件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
1842TERIFLUNOMIDE HMR17261件: Teriflunomide1件: Teriflunomide 💬1件: DHODH 💬3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬1件: 13 💬
1843Testosterone1件: Testosterone1件: Testosterone 💬1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬8件: 1, 2, 3, 13, 60, 76, 78, 113 💬
1844Testosterone undecanoate3件: Testosterone,
Testosterone undecanoate,
Undecanoic acid		2件: Testosterone ,
Testosterone undecanoate 💬		1件: AR 💬4件: Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬2件: 13, 60 💬
1845Tetanus diphtheria toxoid vaccine (Td)1件: Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)---1件: 13 💬
1846Tetanus diphtheria toxoids vaccine----1件: 13 💬
1847Tetanus toxoid1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---4件: 13, 14, 46, 50 💬
1848Tetanus toxoid (TT) containing vaccine (Td, Tdap)1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 13 💬
1849Tetanus toxoid vaccine1件: Clostridium tetani toxoid antigen (formaldehyde inactivated)---1件: 13 💬
1850Tetanus, diphtheria, and acellular pertussis vaccine1件: Pertussis vaccine1件: Pertussis vaccine 💬--1件: 13 💬
1851Tetracycline1件: Tetracycline1件: Tetracycline 💬--4件: 13, 46, 53, 97 💬
1852Tetracycline - Statin - Antimycotic1件: Tetracycline1件: Tetracycline 💬--1件: 13 💬
1853Tetrahydrocannabinol1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬4件: 8, 13, 36, 298 💬
1854Tetrahydrocannabinol (THC)1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1855TETRAHYDROCANNABINOL Botanical Drug Substance (THC BDS)1件: Dronabinol1件: Dronabinol 💬2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1856TG----2件: 13, 37 💬
1857TG-1101----1件: 13 💬
1858THC----5件: 8, 13, 36, 46, 96 💬
1859THIOPLEX----1件: 13 💬
1860Thiotepa1件: Thiotepa1件: Thiotepa 💬--12件: 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284, 285 💬
1861THYMOGLOBULINE1件: Antithymocyte immunoglobulin (rabbit)---5件: 13, 36, 51, 60, 96 💬
1862Thymoglobuline®1件: Antithymocyte immunoglobulin (rabbit)---1件: 13 💬
1863Thymol1件: Thymol1件: Thymol 💬--1件: 13 💬
1864Tissue Selective Estrogen Complex----1件: 13 💬
1865Tizanidine1件: Tizanidine1件: Tizanidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
1866Tizanidine (sublingual or oral)1件: Tizanidine1件: Tizanidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
1867Tizanidine hydrochloride capsule1件: Tizanidine1件: Tizanidine 💬3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
1868TMP001----1件: 13 💬
1869Tocilizumab1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬21件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
1870Tocilizumab Injection1件: Tocilizumab1件: Tocilizumab 💬1件: IL6R 💬12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1871Tocopherol1件: Tocopherol1件: Tocopherol 💬--5件: 13, 49, 206, 257, 298 💬
1872Tolebrutinib----2件: 11, 13 💬
1873Tolebrutinib 120mg----1件: 13 💬
1874Tolebrutinib 60mg----1件: 13 💬
1875Tolerogenic dendritic cells (tolDC)----1件: 13 💬
1876Tolerogenic Dendritic cells loaded with myelin peptides1件: Myelin basic protein---1件: 13 💬
1877Tolerogenic Fibroblasts----1件: 13 💬
1878Tolperisone1件: Tolperisone1件: Tolperisone 💬--1件: 13 💬
1879Tolperisone HC11件: Tolperisone1件: Tolperisone 💬--1件: 13 💬
1880Tolperisone HCl1件: Tolperisone1件: Tolperisone 💬--1件: 13 💬
1881Tolpersan----1件: 13 💬
1882Tolposan----1件: 13 💬
1883Topical Preparation H arm----1件: 13 💬
1884Torvast----1件: 13 💬
1885TORVAST*10CPR 10MG----1件: 13 💬
1886Tovaxin----1件: 13 💬
1887Tovaxin Autologous T Cell Vaccine----1件: 13 💬
1888Tracleer1件: Bosentan2件: Bosentan ,
Bosentan 💬		2件: EDNRA,
EDNRB 💬		9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 13, 51, 84, 85, 86, 88, 210, 211 💬
1889Trancopal----1件: 13 💬
1890Trancopal Dolo----1件: 13 💬
1891TREOSULFAN1件: Treosulfan1件: Treosulfan 💬--6件: 13, 19, 62, 65, 283, 286 💬
1892Trichuris suis eggs----3件: 13, 96, 97 💬
1893Trichuris suis Ova----4件: 13, 46, 96, 97 💬
1894Trichuris suis ova (eggs), embryonated, viable----1件: 13 💬
1895Trileptal1件: Oxcarbazepine1件: Oxcarbazepine 💬5件: SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬1件: 13 💬
1896Triomar™ (omega-3 fatty acids)1件: Omega-3 fatty acids---1件: 13 💬
1897Trivalent seasonal influenza vaccine----1件: 13 💬
1898Trulicity1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
1899Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
1900Trulicity 0,75 mg injekcný roztok naplnený v injekcnom pere.1件: Dulaglutide1件: Dulaglutide 💬1件: GLP1R 💬3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 13 💬
1901TSO----3件: 13, 46, 97 💬
1902TT Vaccine----1件: 13 💬
1903TV-5010----1件: 13 💬
1904TV-5600----3件: 8, 13, 96 💬
1905Tylenol Pill----1件: 13 💬
1906TYSABRI1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬3件: 13, 25, 63 💬
1907TYSABRI 300 mg concentrado para solución para perfusión1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1908TYSABRI 300 mg concentrate for solution for infusion1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1909TYSABRI 300 mg solution à diluer pour perfusion1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1910TYSABRI and AVONEX2件: Interferon beta-1a,
Natalizumab		2件: Interferon beta-1a ,
Natalizumab 💬		3件: IFNAR1,
IFNAR2,
ITGA4 💬		30件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Focal adhesion, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Regulation of actin cytoskeleton, Toll-like receptor signaling pathway, Yersinia infection 💬1件: 13 💬
1911Tysabri Injectable Product1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1912Tysabri ® (Natalizumab)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1913TYSABRI*IV 1FL 300MG 15ML1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1914TYSABRI®1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1915Tysabri® (natalizumab)1件: Natalizumab1件: Natalizumab 💬1件: ITGA4 💬14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬1件: 13 💬
1916UBLITUXIMAB1件: Ublituximab1件: Ublituximab 💬1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13 💬
1917Ubltuximab----1件: 13 💬
1918Ucb L059----1件: 13 💬
1919UK: Sativex Oromucosal Spray2件: Cannabidiol,
Dronabinol		2件: Dronabinol ,
Cannabidiol 💬		2件: CNR1,
CNR2 💬		4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬1件: 13 💬
1920Ultomiris1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬6件: 2, 11, 13, 50, 62, 66 💬
1921ULTOMIRIS®1件: Ravulizumab1件: Ravulizumab 💬1件: C5 💬11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 13 💬
1922Ultra small particles of iron oxide (USPIO)1件: Ferric oxide1件: Ferric oxide 💬--1件: 13 💬
1923Ultrasmall particles of iron oxide1件: Ferric oxide1件: Ferric oxide 💬--1件: 13 💬
1924Ultromiris----1件: 13 💬
1925Umbilical cord derived Mesenchymal Stem Cells----1件: 13 💬
1926Umbilical cord mesenchymal stem cells----5件: 13, 46, 57, 97, 113 💬
1927Undecanoate1件: Undecanoic acid---2件: 13, 60 💬
1928UNDIFFERENTIATED AUTOLOGOUS MESENCHYMAL STEM CELLS----1件: 13 💬
1929Untreated to atorvastatin treatment1件: Atorvastatin1件: Atorvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬
1930Urbason----3件: 13, 97, 222 💬
1931Urbason 40 mg----1件: 13 💬
1932URBASON 40 mg comprimidos----1件: 13 💬
1933URBASON FORTE----1件: 13 💬
1934Urbason solubile forte 1000mg----1件: 13 💬
1935Urbason® solubile forte 1000 mg----1件: 13 💬
1936Urine samples----1件: 13 💬
1937UVEDOSE 100 000 UI----1件: 13 💬
1938UVEDOSE 100 000 UI, solution buvable en ampoule----1件: 13 💬
1939V08CA02----1件: 13 💬
1940V08CA09----1件: 13 💬
1941Vaginal estriol1件: Estriol2件: Estriol ,
Estriol tripropionate 💬		2件: ESR1,
ESR2 💬		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬1件: 13 💬
1942Vancomycin1件: Vancomycin1件: Vancomycin 💬--8件: 13, 46, 70, 94, 96, 97, 296, 299 💬
1943Vardenafil1件: Vardenafil1件: Vardenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬3件: 13, 86, 299 💬
1944Vardenafil (hidrocloride)1件: Vardenafil1件: Vardenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 13 💬
1945Vardenafilo1件: Vardenafil1件: Vardenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 13 💬
1946VARDENAFILO HIDROCLORURO1件: Vardenafil1件: Vardenafil 💬1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 13 💬
1947Vatelizumab1件: Vatelizumab---2件: 13, 97 💬
1948VAY736----9件: 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
1949VB13S1----1件: 13 💬
1950VB5S2----1件: 13 💬
1951VB6S5----1件: 13 💬
1952Vehicle Gel----2件: 13, 34 💬
1953Venlafaxin Hexal----1件: 13 💬
1954Venlafaxine1件: Venlafaxine1件: Venlafaxine 💬2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬3件: 6, 13, 46 💬
1955VENLAFAXINE HYDROCHLORIDE1件: Venlafaxine1件: Venlafaxine 💬2件: SLC6A2,
SLC6A4 💬		2件: Serotonergic synapse, Synaptic vesicle cycle 💬2件: 13, 46 💬
1956Verum arm receiving Gilenya®----1件: 13 💬
1957Verum arm receiving Vitamin D oil1件: Vitamin D---1件: 13 💬
1958VESIcare 10Mg Tablet----1件: 13 💬
1959VIB0551----1件: 13 💬
1960Vidofludimus1件: Vidofludimus---5件: 13, 46, 94, 96, 97 💬
1961VIDOFLUDIMUS CALCIUM2件: Calcium,
Vidofludimus		---4件: 13, 94, 96, 97 💬
1962Vigantol----4件: 13, 65, 96, 97 💬
1963Vigantol Oel----3件: 13, 96, 97 💬
1964VIGANTOL OIL----1件: 13 💬
1965VigantOL oil plus interferon beta-1a (Rebif)2件: Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
1966Vigantol® Oil----1件: 13 💬
1967Vigantol® Öl 20.000 I.E./ml----1件: 13 💬
1968Vitamin A1件: Vitamin A1件: Vitamin A 💬2件: RARA,
RARB 💬		8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬3件: 13, 53, 90 💬
1969Vitamin D2件: Cholecalciferol,
Vitamin D		1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬20件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 298, 299 💬
1970Vitamin D31件: Cholecalciferol1件: Cholecalciferol 💬1件: VDR 💬5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬12件: 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 💬
1971Vitamin E1件: Vitamin E1件: Vitamin E 💬--11件: 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317 💬
1972Vitamin E/Selenium2件: Selenium,
Vitamin E		1件: Vitamin E 💬--1件: 13 💬
1973VITAMINA D3 KERN PHARMA SOLUCIÓN OLEOSA----1件: 13 💬
1974VSN16R----1件: 13 💬
1975VSN16R 100mg----1件: 13 💬
1976VX15/2503----2件: 8, 13 💬
1977Warfarin1件: Warfarin1件: Warfarin 💬2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬11件: 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91 💬
1978Water1件: Water1件: Water 💬--21件: 2, 5, 6, 13, 17, 22, 35, 46, 53, 57, 63, 65, 67, 78, 84, 96, 97, 206, 226, 278, 299 💬
1979WAY-130799----1件: 13 💬
1980Withhold IS (B cell depletion therapy)----7件: 13, 35, 46, 49, 50, 51, 107 💬
1981Withhold IS (MMF or MPA)----7件: 13, 35, 46, 49, 50, 51, 107 💬
1982Withhold IS (MTX)----7件: 13, 35, 46, 49, 50, 51, 107 💬
1983XCEL-MC-ALPHA----1件: 13 💬
1984Xeomin1件: Botulinum toxin type A1件: Botulinum toxin type A 💬1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬7件: 5, 6, 7, 13, 15, 17, 113 💬
1985Zanubrutinib1件: Zanubrutinib1件: Zanubrutinib 💬1件: BTK 💬7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬5件: 13, 63, 222, 300, 331 💬
1986Zenapax1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1987Zeposia1件: Ozanimod1件: Ozanimod 💬5件: S1PR1,
S1PR2,
S1PR3,
S1PR4,
S1PR5 💬		3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
1988Zinbryta1件: Daclizumab1件: Daclizumab 💬1件: IL2RA 💬11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬1件: 13 💬
1989ZK 157046----1件: 13 💬
1990ZOL446H----1件: 13 💬
1991Zoledronic acid1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬12件: 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333 💬
1992ZOLEDRONIC ACID MONOHYDRATE1件: Zoledronic acid2件: Zoledronic acid ,
Zoledronic acid 💬		1件: FDPS 💬4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 13 💬